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V Abstract 
Turning cells into useful devices to perform unnatural functions creates the potential 
to permit the interface between biological organisms and electronics. In this thesis cell-
based devices were designed and constructed to respond to either light or a specific 
chemical stimulus. Design constraints were defined by the eventual application of the 
device, a biohybrid robot. 
The enzyme endothelial nitric oxide synthase (eNOS) was chosen as a target for 
genetic engineering. Prior to constructing the device a suitable host for the engineered 
construct was selected. CHO-K1 cells were transfected with nitric oxide synthase and 
expression levels were characterized via flow cytometry and inhibitor studies. A novel 
method for the effective delivery of inhibitors was developed and applied to 
demonstrate that transfected eNOS was sufficiently expressed to produce a measurable 
output. In addition, a balance between the native nitric oxide production machinery of 
the cells and the transfected endothelial nitric oxide synthase was observed. 
Two systems were designed and constructed for stimuli responsive nitric oxide 
production. The first system was designed to produce nitric oxide in response to the 
presence of the antibiotic rapamycin. Chemical induced dimerization would bring the 
two separated domains of endothelial nitric oxide synthase into close enough proximity 
to re-establish protein function. The separate oxygenase and reductase domains were 
successfully amplified and subsequently fused with components of the chemically 
induced dimerization system. 
The second system involved fusing a domain from the plant gene Nhp1 (Light 
Oxygen Voltage domain - LOV) capable of harvesting a photon, with mouse endothelial 
nitric oxide synthase. This strategy aimed to hijack the wild type protein’s native 
electron transfer pathway. Manipulation was carried out in bacteria with subsequent 
transfection into CHO-K1 cells. 
Subsequent testing of nitric oxide production the mutant cells confirmed the optical 
sensitivity of the mutant eNOS. Moreover both LOV mutant cell lines were capable of 
fast response times and switching behaviour.  
The findings of this thesis demonstrate that genetic engineering of endothelial nitric 
oxide synthase is a suitable strategy for the controlled release of nitric oxide upon 
optical stimulation. Moreover the potential of an engineered cell to respond quickly to 
stimuli has been realized, comparing favourably to genetically engineered systems that 
rely on gene expression to elicit an output. 
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Chapter 1 Introduction and Literature Review 
 
In recent years the application of genetic engineering to the construction of 
biological devices has received considerable attention. The majority of biological 
strategies for device construction focus on biomolecule-based applications such as 
protein immobilisation on solid state devices. Although more complex, the cell 
engineering approach yields numerous advantages. By turning cells into signal 
transduction agents, a variety of unique applications can be devised, which harness the 
power of the cellular machinery. The first part of this review will focus on the current 
state of the art in sensors and cell based biosensors. 
The successful design of a genetically engineered sensor system requires detection 
of an environmental stimulus by the cell and subsequent response to produce a 
detectable output. A potential cell derived output signal is the signalling molecule nitric 
oxide (NO) which will be reviewed in detail along with its production in vivo via nitric 
oxide synthase (NOS).  
Biosensors that rely upon signals generated via a chemical stimulus, have received 
considerable attention. A novel approach to this transduction route, chemical induced 
dimerization (CID) will be discussed. However, one of the most exciting areas of 
biological device construction relates to the generation of a detectable output in 
response to an optical stimulus. Early applications focused on the use of photoactive 
proteins whilst the emerging field of optogenetics aims to harness the power of genetic 
engineering to create cellular responses to light.(Deisseroth, 2011)  In the final section 
of this chapter the areas of photoactive sensors, proteins and optogenetics will be 
reviewed with respect to device applications.  
   
1.1 Cyberplasm - the construction of a semi autonomous biohybrid robot 
 
Synthetic biology can be described as the use of engineering principles to build 
useful devices from biological building blocks or using unnatural building components 
in biological systems. This definition can be taken one step further to include the 
complete design and construction of artificial organisms.  
Recent advances in robotics design using nature as an inspiration include the 
biomimetic variety pioneered by Ayers et al.(J. Ayers & Witting, 2007), (J. Ayers & 
Rulkov, 2010). This approach has been successful in imitating some of the behavioural 
advantages of marine animals such as the lobster and lamprey. The Cyberplasm project 
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aims to harness the power of synthetic biology at the cellular level by exploiting 
bacteria and mammalian cells to carry out device like functions. In addition this 
exploitation aims to allow the cells to communicate with the robot electronics thus 
addressing the integration between bio and robot components. Furthermore synthetic 
biology is attempted at a larger scale by interfacing multiple cellular devices together, 
connecting to an electronic nervous system and in effect creating a multi-cellular 
biohybrid robot. Motile function will be achieved by engineering muscle cells to 
contract upon light stimuli allowing movement of the robot to be powered by 
mitochondrial conversion of glucose to ATP. 
The Cyberplasm project aims to build a biohybrid microrobot capable of 
autonomous behaviour. This robot will be a hybrid of both synthetic parts and 
biologically engineered cellular components. Interfacing the biological and synthetic 
components is one of the key challenges in building such a machine that will be 
achieved by transforming mammalian cells into sensors and actuators, respectively. The 
overall design is presented in Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Schematic representation of the Cyberplasm micro-robot. Synthetic 
muscle propels the robot through liquid. Synthetic sensors, either photoreceptive 
or chemoreceptive, will report signals from the immediate environment. These 
signals will in turn be processed via the electronic components. An electronic brain 
will control signal impulses to drive the muscle cells by causing a biomimetic 
neurotransmission. Power for the muscle units will be derived from the 
mitochondrial conversion of glucose to energy. The source of glucose will be 
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constructed within the hydrogel/polymer body and delivered to the muscle cells in 
a controlled fashion.  
 
Modification of myoblasts (muscle cells) will be attempted in order to produce 
actuators capable of propelling the robot through fluid. Firstly a controllable assembly 
of myotubes will be performed by harnessing flipped SNAREs (soluble N-
ethylmaleimide-sensitive fusion protein attachment protein receptors) and a Tet-Off 
gene expression system.  The miniaturization of Cyberplasm cannot accommodate a 
power supply with sufficient power for electrical stimulation of myotubes. Therefore a 
controlled iontophoresis of acetylcholine (Ach) to simulate myotubes will generate 
contraction. Another option for the electronic controlled stimulation of muscle will be 
attempted by the activation of channelrhodopin-2 whereby shining blue light onto 
muscle causes an increase in intracellular Ca2+ and drives contractions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Block diagram of the control system linking the various components of 
Cyberplasm. 
 
Response of the sensor cells will be used to activate a central pattern generator 
(CPG) for swimming through bilaterally paired CPG neurons, Figure 2. The CPGs will 
be connected through inhibitory synapses and excitatory synapses to generate a swim 
motor program that alternates on the two sides and propagates from the anterior muscle 
to the posterior muscle. This pattern will generate propagating waves of muscle 
contraction that will underlie forward swimming. The CPG neurons will be activated by 
synaptic input from commands that receive inputs directly from the bioengineered 
sensor cells via the electrochemical nitric oxide sensor described in this thesis. Key to 
control of adaptive behaviour of the robot is rapid response of the sensors to changing 
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environmental conditions. Achievement of this goal requires that the reporter operates 
with a short time-constant. The sensors are in effect the "eyes" and "nose" of the robot 
and the development of these sensors is the subject of this thesis. 
Cyberplasm integration will be accomplished via a combination of nano/microscale 
fabrication and matching the synthetic biology with materials development.  The body 
of Cyberplasm will have several functions. Its core will consist of a hydrogel with 
tuneable mechanical properties and a polydimethylsiloxane (PDMS) based microbial 
fuel cell. The hydrogel will be modified using microscale patterning of PEI to allow for 
adhesion of myotubes. Additionally, mechanical properties of the hydrogel will be 
tuned via crosslinking to allow maximum motile propulsion of myotubes. Electronic 
connections will be fabricated using evaporated gold on a PDMS skeleton frame. This 
frame will be the basis of a highly novel microbial fuel cell to power the electronic 
brain, photodiodes and LEDs. The work undertaken in this thesis aims to create 
Cyberplasm's sensory mechanisms using a cell-based biosensor capable of generating a 
chemical signal upon stimulation which will be converted to electrical current via the 
use of an electrode. 
  
1.2 Current technology for measuring biologically derived signals 
 
The majority of biosensors harness naturally occurring reactions to create a 
measurable output, often with an intermediate signal transduction step.  Sensor systems 
exhibiting quantitative measurements rely on the scalability of the reaction being 
measured. There are various criteria that must be addressed in the design of new sensor 
systems. They include sensitivity, selectivity, stability, artefact minimization, power 
consumption, analytical capabilities, reliability and cost.(Hanrahan, Patil, & Joseph 
Wang, 2004)  
 
1.2.1 Micro electrode arrays 
 
Micro Electrode Arrays (MEAs) originated in the 1980's, when progress in 
microelectronic technology made it possible to accurately measure low currents and 
produce very small electrodes. Using this principle, electrodes have been modified to 
detect the presence of penicillin(Nishizawa, Matsue, & Uchida, 1992) and to 
simultaneously detect O2, H2O2 and Glucose. In addition MEAs have been developed 
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to measure electrical activity in cultured neurons at both the network and single cell 
level.(Ben-Jacob & Hanein, 2008)  
Micro-Electrode arrays come in a variety of designs, Figure 3. The type of design is 
usually dependant on the application in question, as an example, design A from Figure 3 
would be appropriate for detection of a single reaction from a sample, design C would 
be appropriate for the detection of multiple analytes from a single sample and design D 
would be appropriate for detecting a single reaction from multiple samples.  Electrodes 
in the array can be made selective towards a variety of compounds by either applying a 
different potential per electrode or by chemical surface modification.  
 
 
 
 
Figure 3 Diagram showing a variety of microelectrode arrays. A) Microdisk B) 
Microring C) Microdisk array D) Nanolithographically produced microband 
array E) Microcylinder F) Microsphere G) Microhemisphere H) Fiber array. 
Adapted from (Amatore, Holub, & Marecek, 2000). 
 
 
1.2.2 Light addressable potentiometric sensor (LAPS) 
 
An example of a solid-state sensor suitable for measurements in biological systems 
is the Light-addressable Potentiometric Sensor (LAPS). When light of an appropriate 
wavelength is applied to the sensor, electron-hole pairs are formed. These subsequently 
become separated in the depletion layer as electrons move towards the silicon and holes 
accumulate at the insulator-silicon interface. This leads to a separation of charge which 
moves in the external circuit such that can it be detected by an ammeter. Surface charge 
is pH dependent and that any change in pH can be measured by determining the shift in 
the photoresponse curve from its starting position at any pH value. The change in pH is 
A) B) C) 
E) F) G) 
D) 
H) 
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only measured at the locations that are illuminated, Figure 4. Each LED can be turned 
on independently allowing for a local pH measurement due to the discrete chemistries 
present at the sensor surface.(John C Owicki et al., 1994) 
LAPS systems were initially used to measure the electric properties of phospholipid 
bilayer membranes. In this instance, membrane capacitance, conductance and 
transmembrane potential were measured.(Sigal, D. H. Hafeman, J. W. Parce, & 
McConnel, 1989) A major limitation is that it can only measure processes which 
produce a change in pH. Fortunately there are many such processes including those 
mediated by T cell receptors, G-coupled receptors, Haematopoietic-family of receptors 
and ligand gated ion channels.(Nag, H. G. Wada, Fok, Green, & S. D. Sharma, 
1992),(Nag, H. G. Wada, Deshpande, Passmore, & Kendrick, 1993),(J.C. Owicki, J. W. 
Parce, Kercso, Sigal, & Muir, 1992),(Raley-Susman, Miller, J.C. Owicki, & Sapolsky, 
1992),(H. G. Wada, Indelicato, Meyer, Kitamura, & Miyajima, 1993) 
 
 
 
Figure 4  Schematic representation of the LAPS sensor (adapted from Owicki et 
al).(John C Owicki et al., 1994) An electrode in the aqueous buffer works as both a 
controlling and a reference electrode. Ground potential is selected as the potential 
of the non-insulated area. Potential is then altered using a potentiostat (depicted by 
Ψ) so that the solution is negative in comparison with the potential of the silicon. 
The potential remains relatively constant up to a few nanometres of the insulator 
surface. The LAPS therefore measures Ip (alternating photo-current) 
 
Discrete 
Chemistries 
Insulator 
LED’s 
Aqueous 
Buffer 
Ψ 
Ip 
Ohmic 
Contact 
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1.2.3 Amperometric sensors 
 
Electrochemical sensors can also function amperometrically, in which case the 
potential difference caused between the working and reference electrodes is used to 
induce a change in oxidation state of the target chemical compound. This is nearly 
always an electroactive species and the resulting change in current caused by this 
reaction is measured.(Stradiotto, Yamanaka, & Zanoni, 2003) In the case of solid state 
electrodes, surface modification has allowed for the design and construction of sensors 
for a variety of applications. This modification is usually achieved by altering surface 
chemistries. Bioactive reagents can be placed onto the electrode as a coating which will 
cause a redox reaction when in contact with the appropriate analyte, which will in turn 
produce a detectable amperometric response (in other words, a change in 
current).(Stradiotto et al., 2003) The immobilization of the bioactive reagent can be 
achieved by a variety of processes, such as chemisorption, polymer coating, chemical 
reactions or composite formation.(Murray, Ewing, & Durst, 1987) Examples of this 
include the modification of carbon electrodes with tetraruthenated cobalt porphyrin for 
the detection of nitrites/nitrates,(J. R. C. Rocha, Angnes, Bertotti, Araki, & Toma, 2002) 
modification of carbon electrodes with cellulose acetate and uricase for the detection of 
uric acid(Markas, Gilmartin, & J. P. Hart, 1994) and the modification of a platinum 
electrode with nickel tetrasulphonated phtalocyanine for the detection of nitric 
oxide.(Guo, Murohara, Buerke, Scalia, & Lefer, 1996) The use of pre-concentrating 
agents to achieve a higher degree of selectivity has been well documented. These are 
usually ion-exchange polymers which confer increased selectivity towards the specific 
analyte, and act by either conferring size exclusion properties, charge exclusion 
properties or state exclusion properties (i.e. permeability to gases but not liquids). This 
is advantageous as it eliminates contact of unwanted reagents with the electrode and by 
doing so increase the concentration of the desired analyte near the electrode surface. 
Examples of this include Nafion, poly(vinyl sulphate), poly(L-lysine), deprotonated 
poly(acrylic acid) and cellulose acetate.(Stradiotto et al., 2003)   
Amperometric electrodes have  been modified to function as biosensors by using 
enzymes as the oxidising/reducing agent. This allows for the detection of a variety of 
biological entities such as metabolites or drugs within a biological fluid. These types of 
sensors are particularly successful if the enzyme in question is an oxygenase or a 
dehydrogenase as these produce a very noticeable change in current at the electrode 
surface.(Joseph Wang, 1999) 
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Simple deposition of enzymes on to the electrode surface would lead to the creation 
of a barrier for detection of the redox reaction, thus enzymes are immobilized at a 
discrete distance from the electrode. Strategies to achieve this immobilization include 
tethering of the enzyme using redox relay units, the use of diffusional mediators and 
immobilization of the protein using redox polymers.(Joseph Wang, 1999),25 
Examples of this type of sensor modification include a lactate dehydrogenase based 
sensor, capable of measuring lactate concentrations in blood samples. Irregularities of 
lactate levels have been linked to medical conditions such as hypoxia and lactic 
acidosis. In order to achieve this, NAD+ dependent lactate dehydrogenase was 
immobilized onto an electrode using the ferricyanide ion as a mediator.(N. Sato & 
Okuma, 2006) 
 
 
 
Figure 5 representation of the reaction occurring at the electrode interface for the 
lactate sensor developed by (N. Sato & Okuma, 2006). 
 
1.2.4 Field Effect Transistors  
 
Ion selective field effect transistors (ISFET) are based on normal FETs where the 
solid state device is capable of both high-input and low out-put impedance. By this 
principle, the device becomes able to measure charge build-up across the ion-selective 
membrane. FETs were the first fully miniaturised silicon sensors, having been invented 
in the 1970's, and have been used to create a variety of sensors.(Schoning & 
Poghossian, 2002) FETs are made using micro-fabrication techniques, which while 
substantially increasing their manufacturing cost does make them very small and so 
makes it possible to create a full array capable of sensing a variety of analytes which 
can be incorporated into an in vivo application.(Stradiotto et al., 2003) FET's were 
originally designed to work at relatively low end applications (unlike silicon 
technology) and as such were not expected to run processes such as computer memory, 
and instead became components of lower end technology such as ID tags and Smart 
Cards.(H. E. Katz & Bao, 2000) Due to its chemical tuneability and ease of 
construction, the FET sensor has been adapted for a variety of uses. 
lactate + NAD+ 
NAD+ + 2Fe(CN)64- + H+ 
pyruvate + NADH 
NADH + 2Fe(CN)63- 
diaphorase 
lactate dehydrogenase 
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The FET works by measuring the current between a source and drain electrodes 
which occurs when a voltage is applied to the gate. When there is no current flowing 
between source and drain, the gate is "off" and when voltage is applied to the semi-
conductor, a charge forms between the semiconductor and dielectric layer causing a 
subsequent increase in current between source and drain electrodes, effectively turning 
the gate "on". For a representation of this, refer to Figure 6.(H. E. Katz & Bao, 2000) 
The principle behind the employment of FET's as biosensors is relatively 
straightforward. Cells are grown on a silicon chip composed of many FET gates, Figure 
6. When the gate is "open", the bioelectric potential can be measured as FET's were 
shown to function when detecting electrolytes. The challenge has been to find a way to 
couple the cell's electric signal into the FET electronic circuit.(Neher, 2001) 
 
 
 
 
 
Figure 6 Representation of the FET system, where gate logic is employed. Adapted 
from (H. E. Katz & Bao, 2000). 
 
1.2.5 Lab on a Chip sensors  
 
The lab on a chip (LOC) concept is an extremely popular one due to its many theoretical 
advantages. These largely rely on the fact that the system can be tuned to allow 
genomic, proteomic or cellular analysis.(Weigum, Floriano, Christodoulides, & 
Mcdevitt, 2007),(Ali et al., 2003). In theory, it is possible to compile enough data 
running a single sample in experiment to determine a diagnosis. The aim of the LOC is 
to be able to run a small scale sample through a single or battery of tests (depending on 
the required amount of data) run on a chip (a microfluidic network which exposes the 
sample to a variety of conditions including the presence of proteins, nucleotides, 
Substrate (Gate) 
Dielectric 
Drain Source Semiconductor 
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antibodies or antigens) which can then be assessed via either an optical or electrical 
signal, depending on the method of detection employed in the design.(Weigum et al., 
2007)  
The work of Mehnaaz et al shows a successful design for a LOC application with 
the function of sorting DNA sequences as well as detecting point mutations using 
fluorescence marking.(Ali et al., 2003) Aldehyde-terminated agarose microspheres were 
bound to avidin docking sites via amination. Subsequently, biotinylated sequences 
complementary to the target sequences are bound to the bead, which is immobilized on 
a silicon chip. The sample is then pumped through the environment containing the bead 
and the target sequence binds to the bead. This was proven using fluorescently marked 
target sequences. This shows much promise to this system which has the potential of 
significantly increasing the efficiency of current DNA sequence detection methods due 
to its higher probing surface area which leads to higher detection rates.(Ali et al., 2003) 
The avidin-biotin interaction can also be harvested for many other applications, 
providing further directions of research using the principles demonstrated by the above 
mentioned sensor design.   
An example of another such LOC application can be found in the work of Shannon 
et al.(Weigum et al., 2007) In this example, the application works via production of a 
fluorescent signal in the presence of epidermal growth factor receptor (EGRF), a marker 
for oral cancer. Using a fluorescently labelled EGRF biomarker, the system produces a 
fluorescent signal which can be detected by harnessing the design of the LOC. In this 
case, cells are immobilized on a membrane from culture by the filter capture method of 
membrane use and can subsequently be used for expression monitoring and 
fluorescence labelling. The system designed by the group shows some of the required 
steps for many such systems and is also limited in the same way that many such systems 
are. It contains microfluidic channels which lead to the membrane to trap the cells and 
dispose of waste. The immobilization of cells allows their imaging and the acquisition 
of data using fluorescence cytometry.(Weigum et al., 2007) 
 
1.3 In Situ vs. In vitro sensors  
 
In Situ sensors require additional operational characteristics in order to be viable. 
The sensor has to be small, resistant to bio-fouling, present an appropriate degree of 
selectivity (low noise generated by co-existing compounds) and be resistant to a variety 
of changes in natural conditions. Biofouling is one of the major causes of in vivo sensor 
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failure. It is caused by accumulation of compounds, proteins and cells on the 
sensor/membrane surface and causes a rapid deterioration in sensor 
function.(Wisniewski & Reichert, 2000) In vitro, sensors can be more delicate and the 
conditions for detection can be perfected but this comes at a cost. In vitro experiments 
not only fall short of in situ experiments in as much as the conditions do not represent 
what is actually happening in the system being examined, but in addition the sample 
must be processed prior to examination adding time and cost to the application of the 
sensor particularly in the healthcare sector.  
In situ sensors have stringent biocompatibility requirements. The insertion of foreign 
material into the human body brings about immediate physiological responses which 
vary in accordance to the environment they are introduced to, i.e. blood, tissue or bone. 
These responses can ultimately lead to a wide variety of possible interactions with the 
sensor, affecting its performance.(Shin & Schoenfisch, 2006) Examples of this include 
biofouling in blood via adhesion of platelets or protein deposition in intravascular 
sensors which causes a subsequent drop in sensor quality, be it in sensitivity or 
longevity.(Frost, Rudich, H. Zhang, Maraschio, & Meyerhoff, 2002) Strategies towards 
improving sensor survivability in these conditions include selection of materials known 
to not cause an immune response (such as those developed for the prosthetics industry) 
and the localized attenuation of host response using co-factors known to alleviate the 
sensor integration procedure. An example of this is mentioned in the work of Frost et 
al(Frost, Rudich, H. Zhang, Maraschio, & Meyerhoff, 2002) where the use of nitric 
oxide is employed to improve sensor lifetime by discouraging cell/platelet adhesion to 
the sensor. This study showed that when an NO releasing membrane was added to the 
sensor, bacterial adhesion was drastically reduced when compared to the control.(Frost, 
Rudich, H. Zhang, Maraschio, & Meyerhoff, 2002) However, limitations as to the 
longevity of NO releasing polymers/substrates make it so that long term activity of NO 
release in situ around the electrode is not currently possible using this approach.(Shin & 
Schoenfisch, 2006) 
Sensors implanted sub-cutaneously face a different set of challenges as the main 
responses causing sensor degradation include cell-adhesion and sensor encapsulation by 
fibrous tissue. The implantation procedure in these cases initiates the body's healing 
mechanism by damaging capillaries or simply displacing tissue. This triggers a series of 
responses starting with the inflammatory response, which causes the adsorption of 
proteins and inflammatory cells onto the sensor. Phagocytic cells then surround the 
sensor, attempting to destroy it. These events are detrimental to the sensor in as much as 
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they cause the accumulation of matter on the sensor surface restricting the functional 
area designed for analyte/sensor interaction. Phagocytic cell binding also causes the 
consumption of some analytes such as glucose and oxygen whilst producing highly 
active free radicals (peroxygen, superoxide, nitric oxide, etc) which can interact either 
with the sensor directly causing background noise or with the analyte, reducing detected 
analyte concentration and so dampening the signal perceived by the sensor.(Shin & 
Schoenfisch, 2006) As the body's healing mechanism continues to take action, the tissue 
surrounding the foreign material becomes increasingly constricting and avascular, 
cutting off the potential sensor from the analyte it should be measuring.(Shin & 
Schoenfisch, 2006) 
In addition to the effect of the sensor itself on the organism it is inserted to, there is 
also contamination to consider. The introduction of foreign organisms such as bacteria 
during sensor implantation or even the concentration of such species at the sensor/host 
interface can lead to complications. Sterilization techniques exist to prevent this from 
happening, however, this process can many times damage the sensor particularly 
membrane containing sensors. In these cases, temperature/chemical sterilisation can 
lead to polymer degradation and so cause sensor damage, whilst not even guaranteeing 
complete sensor sterilization. Common cases of implant associated infections occur 
from bacterial biofilm formation on the sensor surface. This implies that bacteria have 
formed colonies capable of creating these biofilm protective layers of 
exopolysaccharides which provides the colonies with immunity from the host immune 
system as they can neither be phagocytosed nor attacked by antibodies. Unfortunately, 
this biofilm formation also renders them immune to antibiotics as it acts as a chemical 
barrier, resulting in a necessity to remove the implanted sensor.(Shin & Schoenfisch, 
2006) 
A variety of metal contaminant sensitive electrodes have been designed and 
constructed seeing as they have a variety of applications and their miniaturization is less 
of a critical factor as they can be used to detect large volumes of sample. One such 
sensor, described in the work of Wang et al,(Joseph Wang et al., 1997) focused on the 
detection of uranium and nickel using a potentiometric glass carbon disk electrode 
system. To this effect, the electrode surface was modified with propyl-gallate (for 
uranium detection) and dimethylglyoxime (for nickel detection) and the sensor showed 
a good amount of selectivity towards these analytes. However, the necessary 
accumulation period for the analyte meant that the sensor was only effective after at 
least a two minute accumulation period of the sample. Although the degassing step 
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necessary for many other equivalent systems had been neutralized in this instance as the 
system was capable of detecting mg/mL concentrations of the analyte without the 
degassing step. Sensitivity of the sensor depended on the analyte flow rate, with nickel 
sensitivity increased by increasing flow rate to above 10 μL/min and uranium sensitivity 
decreasing above said rate. A further limitation of this system is that it relies on the 
continuous delivery of the sensing ligand to the receptor as well as the analyte in 
question, thus limiting its in situ application.(Joseph Wang et al., 1997)   
 
1.4 Cell-based Biosensors 
 
Cells are equipped with a variety of receptors capable of transducing chemical 
signals into electrical ones. It is suggested that by coupling these cellular properties with 
an electrical readout it is possible to effectively use cells as biosensors for a variety of 
applications such as pharmaceutical screening and environmental monitoring.(Neher, 
2001) The main advantages of cell-based biosensors are as follows:  
 
Self-replicating - as cells divide the sensor is perpetuated. 
Specificity - cells are highly specific through receptor based activation of signalling     
cascades 
Complexity - cells are capable of performing simultaneous tasks 
Stability - biochemical reactions within the cell are enclosed within the protective 
cell membrane, preventing biofouling of internal components. 
 
The disadvantages of cell-based biosensors include: 
 
Limited operating environment - cells require environments with varied but specific 
conditions. Although a type of cell can be found to survive virtually every naturally 
existing environment (including within another organism), each cell is restricted to its 
own specific operating conditions.  
Complexity - With multiple events occurring simultaneously and with interrelated 
processes it can be difficult to focus on one pathway without interfering with/affecting 
another. 
 
Cells can create signals of varied natures, including chemical, optical and electrical. 
Currently, there are several existing methods for extracellular potential measurement, 
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including microelectrode arrays (MEA)(Valderrama et al., 1995),(Amatore et al., 
2000),(Bakker & Telting-diaz, 2002), field effect transistors (FET)(H. E. Katz & Bao, 
2000),(Schoning & Poghossian, 2002),(Neher, 2001), light-addressable potentiometric 
sensors (LAPS)(John C Owicki et al., 1994),(G. Xu et al., 2005) and patch-clamp.(G. 
Xu et al., 2005) These methods, particularly microelectrode arrays and field effect 
transistors, allow for monitoring of cell potential over a prolonged periods of time (days 
or weeks) and are non invasive. Their major limitation comes from only being able to 
record data from electrically active cells such as neurones.(C. K. Young, Ingebrandt, 
Krause, Offenhauser, & Knoll, 2001) In addition, sensor construction relies on the use 
of microelectronic-fabrication techniques which have limited resolution of feature 
separation of 50-200 μm.(G. Xu et al., 2005),(George, Parak, & Gaub, 2000) 
Cells have inherent limitations when used as sensors. In biological tissues cells are 
separated from each other by gaps of 10-20 nm. When grown on artificial surfaces, 
these gaps are at a minimum of 40 nm which limits cell density in artificial 
devices.(Neher, 2001) Cell adhesion also poses a difficulty in the construction of cell-
based biosensors. If the gap between the cells and the silicon chip is too large (usually 
due to the thickness of the electrolyte layer), the contact resistance is increased, which 
leads to current leakage through the electrolytes. Reducing the gaps between cells and 
the gaps between cell and chip is necessary to improve the sensitivity of the 
system.(Fan, 2001) 
Rainina et al (Rainina, Efremenco, & Varfolomeyev, 1996) produced a cell-based 
sensor utilizing cryoimmobilized E. coli cells capable of hydrolyzing organophosphate 
neurotoxins. Its Modus operandi relied on cell produced organophosphate hydrolase 
cleaving P-O, P-S, P-F and P-CN bonds, generating two protons per cleavage event.  
Quantity of protons released was directly proportional to the amount of hydrolyzed 
organophosphate.  A sensitivity of 0.001 mM to 1 mM was achieved with a response 
time of between ten and twenty minutes. The immobilized cells were found to be 
hydrolytically active for over two months when placed at 4 °C in a potassium phosphate 
buffer.(Rainina et al., 1996) 
Further examples of the application of cell based sensor technology in the medical 
field can be found in the work of Rider et al.(Rider et al., 2003) They have developed a 
pathogen sensor based on B-cell recognition with a detection limit as low as 20 colony 
forming units (cfu) for the chosen pathogen.(Rider et al., 2003)  The work shown by 
this group exemplifies an existing sensor type called CANARY (cellular analysis and 
notification of antigen risks and yields). It relies on the genetic modification of B cells, 
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causing the secretion of aequorin in the cytosol and the introduction of specific 
antibodies into the cell membrane. Aequorin is a bioluminescent calcium sensitive 
protein. When the appropriate pathogen binds to the antibody mesh on the cell 
membrane the interaction causes an influx of calcium. This can be detected via its 
reaction with aequorin which produces a luminescent photo signal.(Rider et al., 2003)  
Creation of novel cell-based biosensors can take place using one of two routes, 
utilizing pre-existing cellular machinery, or the insertion of foreign genetic material to 
create the bio-sensing properties. Special consideration must be given when inserting 
foreign genetic material to avoid undesirable protein-protein interactions, the 
inactivation of the target protein due to misfolding, or interference caused by 
inappropriate insertion site selection. In addition, the full range of insertion effects, 
primary and secondary, cannot be accurately predicted prior to experimentation. 
 
1.5 Nitric Oxide 
 
Discovered by Joseph Priestley in 1772, nitric oxide is a gaseous molecule that has 
generated considerable scientific interest. The 1998 Nobel Prize in physiology was 
awarded to Robert F. Furchgott, Louis J. Ignarro and Ferid Murad for the implication of 
NO in cellular signalling (Murad, 2005). Nitric oxide is now known to perform a 
number of intra and extracellular functions including lysis within macrophages,(J S 
Beckman & W H Koppenol, 1996) acting as a signalling molecule in both animals and 
plants (Wendehenne, Pugin, & Klessig, 2001) and demonstrating cytotoxic activity 
(both within the producing cell and towards foreign pathogens).(Borutaite & Brown, 
2005) The diffusivity of NO is extremely high (over 3300 µm2/s) and the molecule can 
easily cross the cell membrane making it an ideal messenger.(Xiaoping Liu et al., 2008) 
As such, NO is a ubiquitous mediator of cellular signalling throughout every system of 
complex organisms.(Llorens, Jordán, & Nava, 2002) 
Early in vitro experiments suggested that the molecule is extremely cytotoxic 
however more recently the observed toxicity has been shown to be mostly caused by 
interaction of NO with superoxide, and the subsequent production of peroxynitrite. 
Superoxide may be produced at low concentrations under specific conditions in vivo by 
nitric oxide synthase (NOS) proteins (discussed in section 1.6) facilitating the formation  
of peroxynitrile and wrongly attributing the observed toxicity to the NO 
molecule.(Alderton, Cooper, & Knowles, 2001)  Although termed a free radical, NO 
has limited reactivity due to its structure. The molecule is a 15 electron system resulting 
 16 
in a single unpaired electron. However, as most biologically active compounds contain 
paired electrons in their highest occupied molecular orbital, their binding to NO is 
unlikely, preventing high levels of reactivity and toxicity.(J S Beckman & W H 
Koppenol, 1996) NO does however readily bind to other systems possessing unpaired 
electrons such as other free radicals, transition metals and transition metal complexes 
such as haem.(J S Beckman & W H Koppenol, 1996) Due to its free radical nature, NO 
can easily gain or lose an electron so as to gain a more favourable electron structure. It 
can hence exist as either a radical (NO●), a nitrosonium cation (NO+) or the anionic 
nitroxyl radical NO-.(Neill, Desikan, & Hancock, 2003) 
Despite its expected low reactivity, NO is involved in many physiological processes. 
The earliest reported use for the molecule as a signalling agent was for gastro-intestinal 
relaxation.(Moncada & Higgs, 2006) In this case, NO was found to be present mainly in 
neurones (being produced by type I NOS). Firing of the neurone leads to the creation of 
action potentials which in turn creates an uptake of calcium. This calcium surge 
activates calmodulin and thus enhances NO production. Nitric oxide would then travel 
to smooth muscle cells in the vicinity, binding to guanylyl cyclase, causing an increase 
in intracellular cGMP. The result of this change would be muscular relaxation. The first 
evidence of NO being used as a signalling molecule was reported during investigations 
into a molecule termed EDRF (endothelium-derived relaxation factor). EDRF was first 
discovered in 1980 and was shown to promote muscular relaxation through neuronal 
activation of endothelial cells.(Furchgott & Zawadzki, 1980) Subsequent experiments 
demonstrated that the action of EDRF was inhibited by the presence of the superoxide 
anion and haemoglobin.  In 1987 it was proposed that EDRF might in fact be NO. This 
was a revolutionary suggestion as NO had not been thought to be produced in 
mammals, much less suspected of being produced as a response to a biological signal. 
Further testing comparing the action of laboratory obtained NO to that of EDRF proved 
that the two were one and the same.(Palmer, Ferrige, & Moncada, 1987) This has also 
been demonstrated using genetic knock-out mice. Mice without the type I NOS gene 
have largely distended stomachs similar to the human condition hypertrophic pyloric 
stenosis, a condition in which the pylorus leading from the stomach to the small 
intestine is narrowed and prevents normal digestion.(Mungrue, D S Bredt, Stewart, & 
Husain, 2003) 
Nitric oxide has also been implicated in regulation of blood flow, with evidence 
pointing towards it having a particular role in vasodilator nerves. It has also been 
associated with migraines, erectile dysfunction and the vascular reflex in hypercapnia 
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(increased carbon dioxide levels in blood), as evidenced by NO inhibition 
studies.(Iadecola, F. Zhang, & X. Xu, 1993) However the use of knock-out mice 
suggests that there are also alternative pathways to the hypercapnia vascular 
reflex.(Estevez & Phillis, 1997) Although there is some evidence that points towards the 
relationship between decreased NO and erectile dysfunction, it is not conclusive as such 
problems are also claimed to be age related. Type I NOS production in the penis has 
also been found to be dependent on androgens such as testosterone, which grants more 
credibility towards the functionality of NO in the erection of the penis, but less in 
regards to its direct connection with impotence which could stem from a lack of the 
androgenic hormones due to the ageing process.(Iadecola et al., 1993),(Lue, 2000) 
There are several methods of measuring NO concentration in a sample. The simplest 
approach involves measuring the amount of more stable NO by-products. This method 
has the disadvantage of being an indirect measurement. Moreover environmental 
conditions may affect the formation of the by-products making the estimation process 
less reliable. Another technique, discussed more detail in chapter 4 is direct 
electrochemical measurement. This relies on a surface modified electrode conducting a 
real-time measurement of NO by measuring the amount of redox reactions carried out 
by the molecule at the electrode surface. With correct calibration procedures, the 
amount of NO in the sample can be determined. Finally NO can be "fluorescently 
labelled". This is not actual labelling of the NO molecule itself but using of a compound 
that upon reaction with NO produces a fluorescent output. The most commonly used 
compounds are diaminofluoresceins (DAF's). They react with NO to form 
triazolofluoresceins producing fluorescence in the green light spectrum.(H Kojima et 
al., 1998),(N Nakatsubo, 1998)  
 
 
1.5.1 Nitric Oxide as a Messenger 
 
In contrast to acetylcholine, which is secreted by a transporter and travels to a 
receptor on an adjacent cell's membrane, nitric oxide relies on its uniquely high 
diffusivity to act as a messenger, and its chemical interactions to cause a signalling 
cascade. NO has been shown to act on processes such as the inhibition of platelet 
aggregation, relaxation of smooth muscle, immune regulation and neural 
communication.(H. H. Schmidt & Walter, 1994) 
NO mostly reacts with molecules with unpaired electrons, such as O2, superoxide 
and metal ions/complexes. When it reacts with oxygen, which is present intracellularly 
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at concentrations varying between 20-200 μM it usually forms N2O3 which 
subsequently has the capability of interacting with thiols and amides in the cell, creating 
a potentially cytotoxic effect when present at high concentrations.(Coddington, Hurst, & 
Lymar, 1999),(Mayer & Hernmens, 1997) N2O3 is an intermediary in the reaction of 
NO with oxygen in aqueous solution which is as follows:  
 
4NO + O2 + 2H2O→[ 2N2O3 + 2H2O ]→ 4NO2- + 4H+  
 
NO also reacts with superoxide at diffusion controlled rates to form peroxynitrite, 
ONO2-. This molecule is fairly stable but is readily protonated to form ONO2H+, which 
is extremely reactive. However, a competing reaction between peroxynitrite, glutathione 
and CO2 within the cell is usually preferred. This reaction either oxidises glutathione or 
forms nitrosoperoxycarbonate ONO2CO2-, respectively.(Coddington et al., 1999) Due 
to its inherent reactivity, peroxynitrite has a half life of approximately one second. NO 
also binds at diffusion controlled rates to the haem group of guanylate cyclase, which is 
one of the supposed targets of NO. This reaction increases intracellular production of 
cGMP by a second order of magnitude using nanomolar concentrations of NO. The 
reactivity of glutathione with NO can be explained as a result of its his-bound haem 
which can form a pentacoordinate ferrous nitrosyl complex under aerobic 
conditions.(Stone, Sands, Dunham, & M. A. Marletta, 1995) 
 
 
Figure 7 Diagram of the reaction of Nitric Oxide with Oxygen. Nitric Oxide does 
not dimerize at room temperatures due to unfavourable kinetics. The two 
unpaired electrons of oxygen allow the formation of bonds with nitric oxide 
molecules. The lack of formation of net bonds results in it being more energy 
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favourable for nitric oxide to exist as a monomer as opposed to dinitrogen dioxide. 
Adapted from Beckman  et al. (J S Beckman & W H Koppenol, 1996) 
 
Nitric oxide reacts most readily with haem proteins such as haemogloblin, which 
have been found to scavenge NO almost immediately as shown in Beckman et al,(J S 
Beckman & W H Koppenol, 1996) whilst superoxide dismutase has been shown to 
nearly double the half life of NO.(Palmer, Ferrige, & Moncada, 1987) In vivo, NO 
levels are constantly being reduced due to its contact with the bloodstream, where 
erythrocytes are widely available containing haemoglobin, and the presence of 
superoxide which is a relatively common molecule within cells.  
NO has been found to be capable of inducing apoptosis at high concentrations. 
However, this is mostly due to the formation of reactive nitrogen species such as RNS's. 
Inversely, the role of NO in shear stress induced apoptosis demonstrates an inverse 
effect, the inhibition of apoptosis.(Dimmeler, Hermann, Galle, & Zeiher, 1999) 
 
 
1.5.2 Nitric Oxide in Phagocytosis 
 
In phagocytosis, as in many other processes that are carried out within the cell, there 
is a delicate balance between NO and O2ˉ.(Fang, 1997) Although the NOS and NADPH 
oxidase pathways are regulated independently and in different ways, it has been shown 
that they are co-stimulated by inflammatory signals and that the presence of both free 
radicals allows for the production of several RNS thought to play a part in 
phagocytosis.(Fang, 1997) The presence and potency of intermediates produced by the 
interaction of O2- and NO provides a molecular basis for the relationship between the 
oxidative burst and NOS activity inherent in phagocytosis.(Fang, 1997) NO produced is 
also thought to be valuable for its ability to protect cells from excessive oxidative bursts 
by reducing the level of available prooxidant iron in the cell. This maintains a tolerable 
level of hydrogen peroxide (H2O2) as well as potentially protecting the membrane from 
oxidative damage by reducing rates of lipid peroxidation.(Fang, 1997) It has been found 
that addition of compounds which stimulate NO production via type II NOS reduced the 
efficiency of phagocytosis, whilst inhibiting production of NO enhance it.(Kopec & 
Carroll, 2000) Other findings have revealed the inverse relationship, and the increase of 
NOS II produced NO caused potentiated phagocytosis whilst inhibition using NG-nitro-
L-arginine methyl ester (L-NAME) impaired it.(Fang, 1997) In the former case where 
samples were taken prior to addition of NO generating compounds, it was found that 
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only types I and III NOS were being expressed and thus phagocytosis occurred 
normally, whilst activation of type II NOS impaired phagocytosis.(Kopec & Carroll, 
2000) iNOS or type II NOS are primarily if not solely used to produce NO at levels high 
enough to be toxic, given that the purpose of most cells presenting type II NOS is to 
eliminate foreign organisms such as bacteria, though the phagocytosis of some types of 
bacteria does not seem to elicit an NO response.(Gross et al., 1998),(Weikert, Lopez, 
Abdolrasulnia, Chroneos, & Shepherd, 2000),(B. Zhang, Cao, Cross, Domachowske, & 
Rosen, 2002) Thus, type II NOS produces much higher levels than types I and III which 
are constituently active and so may be implicated in a variety of conditions such as 
chronic inflammation and autoimmune diseases, rheumatoid arthritis and even 
asthma.(Fang, 1997),(Kopec & Carroll, 2000),(Alderton et al., 2001),(Thomassen et al., 
1997) In vitro studies using NO donor compounds have also shown that NO itself has 
antimicrobial activity, inhibiting and even killing bacteria such as Salmonella. NO has 
also been attributed  anti-viral, fungal and anti-parasitical properties as well as being 
involved in the destruction of tumour cells. (Fang, 1997),(Tsai et al., 
1997),(Nascimento, Ribeiro-Dias, & Russo, 1998) In fact, the presence of NO in host 
cells/blood may at least in part, contribute to bacterial symptom suppression in latent 
asymptomatic infection. It has also been found that reducing levels of NO causes 
reactivation of diseases such as Tuberculosis, Epstein-Barr virus and 
Leishmaniasis.(Fang, 1997) It is possible that the function of nitric oxide in T 
Lymphocyte activation is responsible for some of the occurrences described.(Clark, 
Gorman, & Cope, 2007) 
 
1.6 Nitric Oxide Synthases 
 
Nitric oxide synthases (NOS) consist of a family of proteins responsible for cellular 
production of NO. Functional NOS consists of a NOS dimer bound to two calmodulin 
(CAM) proteins and several co-factors. These include (6R)-5,6,7,8-tetrahydrobiopterin 
(BH4), FAD, FMN and iron protoporphyrin IX (haem). In combination with the co-
factors, the NOS complex catalyses the conversion of oxygen, NADPH and L-arginine 
into nitric oxide, citrulline and NADP.(Alderton et al., 2001) 
Mammalian NOS exist in three isoforms, neuronal (nNOS), inducible (iNOS) and 
endothelial (eNOS). All NOS isoforms exist as haploids in the human genome and 
homology between the isoforms is thought to be between 50-60%. Although there are 
several differences between the proteins, such as dependence on co-factors, production 
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type (constitutive or inducible) and the type of cells in which the isoform is present, 
these are not sufficiently well understood to provide a conclusive reason for the 
variation between isoforms.(Alderton et al., 2001) 
nNOS stands out from the other isoforms genetically as it contains a PDZ domain 
(which stands for a region of PSD-95 Disc large/ ZO-1 homology, PSD being post 
synaptic density protein) upstream of the rest of the sequence, which is homologous to 
the other NOS isoforms.(Brenman et al., 1996) The eNOS gene also stands out for 
having a myristoylation and palmytoylation site in its 5' region, a feature which has not 
yet been reported for the other isoforms of the protein.(Thomas Michel, 1999) All of the 
mammalian NOS proteins exhibit a bidomain structure consisting of an oxidase and a 
reductase region, which contain binding sites for the previously mentioned co-factors 
(Figure 8). More detailed information regarding electron flow through co-factors is 
given in Figure 9. 
 
 
Figure 8  eNOS functional domains and Co-factors. Illustration of the functional 
domains of NOS and binding locations respective to domain of co-factors. 
Electrons donated from the conversion of NADPH to NADP+ and H+ proceeds 
along the reductase domain with FMN and FAD acting as electron carriers. The 
electron flow is facilitated by the calcium bound CAM and proceed to the iron 
haem and BH4 co-factors which then catalyse the conversion of L-arginine and 
oxygen into nitric oxide. Figure adapted from Alderton et al.(Alderton et al., 2001)  
 
With the exception of the oxygenase domain of nNOS, the 3D structures for all three 
NOS isoforms have been resolved, including the structure of the protein dimer when 
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bound to co-factors, (Figure 10). This structural information is vital for the purpose of 
designed site-directed mutagenesis as it allows scientists to target areas to modify with a 
significant reasoning towards predicted site function. The three isoforms differ in 
several aspects, including protein size. eNOS contains 1203 amino acids (133 kDa), 
iNOS 1153 amino acids (131 kDa) and nNOS 1403 amino acids (161 kDa). The 
location in the genome is also different with eNOS, iNOS and nNOS being found in 
chromosomes 7, 17 and 12, respectively.(Geller et al., n d),(P. A. Marsden et al., 1992) 
 
 
Figure 9 Schematic representing the electron flow from NADPH to the iron haem 
site which is thought to be responsible for facilitation of the transition of L-
arginine to L-citrulline (adapted from Alderton et al,(Alderton et al., 2001)) A) A 
diagram demonstrating the flow of electrons in eNOS. B) An illustration of the 
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flow of electrons in an eNOS dimer as described in A. C) The catalytic core where 
L-arginine and O2 are converted to citrulline and NO. 
 
 
 
 
 
 
Figure 10 Image depicting the structure of the type III NOS dimer when bound to 
L-arginine and BH4. Dimer formation is necessary in order to render the protein 
functional, therefore a dimer is represented. This image is a result of the fusion of 
the C terminus of 1FOP to the N terminus of 1TLL - both obtained from PDB (a 
protein structure database known as Protein Data Bank provided by the Research 
Collaboratory for Structural Bioinformatics). 1FOP corresponds to the oxygenase 
domain of eNOS. 1TLL corresponds to the reductase domain of nNOS. As 
homology between the two isoforms (nNOS and eNOS) is >50%, this was 
considered to be sufficient to construct the model. Green/Blue shows individual AA 
chains of the dimer. 
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A schematic representation of the NOS genes is given in Figure 11. The 
dimerization of NOS is thought to occur in a similar fashion, irrespective of isoform. It 
is suggested that the dimerization occurs via the oxygenase domain of the proteins, 
creating the reaction pocket containing the haem molecule, the BH4 binding site and the 
L-arginine binding site. This is further stabilized by a zinc tetrathiolate which is located 
at an equidistant point between the two iron haems. Binding of the zinc molecule is 
thought to occur at a highly conserved site within the protein (eNOS Cys99, iNOS 
Cys115) and has been shown to stabilize the dimer formation by forming an additional 
eight hydrogen bonds.(H. Li et al., 1999) The bonds are located four residues distant 
from the BH4 binding site in iNOS, suggesting that the zinc is necessary for stabilizing 
the reaction pocket formed by dimerization and promoting BH4 binding, without 
directly affecting enzyme function. Further dimerization is thought to occur via the 
reductase domains of nNOS and eNOS, but since the crystal structures for these have 
not been elucidated these remain as assumptions. In addition, dimerization appears to be 
stabilized by the binding of BH4 and L-arginine, which suggests that enzyme activity is 
dependent on the presence of both the substrate and co-factors. This was shown by the 
conversion of a nNOS dimer which was found to be superior in resistance to SDS once 
bound to BH4 and L-arginine, though this observation has not been confirmed for the 
other two isoforms.(Klatt et al., 1995) BH4 has been found to bind to the haem 
containing domain of NOS, interacting with the haem molecule in such a way that its 
binding location is immediately adjacent to the L-arginine binding site where the 
catalytic reaction occurs.(Raman et al., 1998)  
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Figure 11 Schematic of the genes of the three NOS isoforms, showing the proposed 
binding sites for various co-factors and other elements required for the formation 
of NO. As can be seen from the figure, nNOS contains an additional domain and 
the proposed dimer formation domains in the reductase domain of the protein (the 
loop between FMN binding domains) is only present in nNOS and eNOS. Dimer 
formation in iNOS is thought to occur within proximal and distal regions of the 
oxygenase domain. ARG: arginine, HAEM (iron protoporphyrin IX haem), FMN: 
flavin mononucleotide, FAD: flavin adenine dinucleotide, NADPH: nicotinamide 
adenine dinucleotide phosphate.(Alderton et al., 2001) 
 
iNOS appears to be less dependent on the reductase domain for dimerization and 
thus is thought to be  more dependent on BH4 binding to stabilize dimers than the other 
two isoforms.(R. C. Venema, Hong Ju, Ryan, & V. J. Venema, 1997) This was 
illustrated by Marletta et al where the isoforms were expressed in a BH4 free 
environment using bacteria. Dimerization occurred more readily with nNOS and eNOS 
than with iNOS. This has been investigated and confirmed using limited 
proteolysis(Lowe et al., 1996) and yeast two-hybrid systems.(R. C. Venema et al., 
1997) 
NOS's produce NO via the conversion of L-arginine to L-citrulline. This reaction 
requires NADPH, L-arginine and O2. The reaction occurs at the L-arginine binding site 
of the NOS dimer and forms one molecule of NO per molecule of L-arginine used. A 
 26 
diagram of this reaction is given in Figure 12. It has been found using fluorescence 
studies that eNOS produces NO at a rate of 50 nM/hour.(N Nakatsubo, 1998) 
Production of NO from iNOS does not depend upon the concentration of calcium unlike 
for  nNOS/eNOS, where in the absence of calcium the enzyme also produces superoxide 
(O-). This tends to react readily with NO, due to the fact that both molecules are super 
radicals resulting in the production of peroxynitrite, a highly cytotoxic compound.(W.H. 
Koppenol, Moreno, Pryor, Ischiropoulos, & J.S. Beckman, 1992) 
 
 
Figure 12 Diagram of the NO producing reactions catalyzed by NOS's. As can be 
seen in the diagram, NOS catalyzes the formation of NO via the conversion of L-
arginine to L-citrulline, using NADPH as an electron donor and oxygen as a 
proton carrier through a condensation reaction. Overall, the reaction requires 1.5 
NADPH molecules, 2 O2 molecules and L-arginine to form one molecule of NO. 
 
On rare occasions NOS have also been found to produce superoxide from NADPH 
oxidation. Of the three isoforms, nNOS appears to allow this reaction more readily than 
either eNOS or iNOS. Superoxide production transpires with a higher frequency when 
the level of BH4 or L-arginine is lower than the Km value or in the presence of NO 
inhibitors such as NG-methyl-L-arginine (L-NMMA).(Sroes et al., 1998),(Xia, L. J. 
Roman, Masters, & J.L. Zweier, 1998) All three isoforms can produce superoxide under 
certain conditions such as those detailed above, and it is proposed that when both free 
radicals are produced they form peroxynitrite from their highly favourable interaction, 
reducing the levels of both molecules in the system. This has only been shown under in 
vitro conditions.(J.S. Beckman, T. W. Beckman, J. Chen, Marshall, & Freeman, 1990) 
eNOS, the endothelial NOS, has been found to be implicated in several areas of 
physiology, mostly pertaining to the formation of smooth muscle tissue and the process 
of angiogenesis.(Mungrue, D S Bredt, Stewart, & Husain, 2003),(Amano, 2002) 
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1.6.1 Regulation of NOS activity 
 
NOS is heavily regulated due to the nature of its products. This regulation is 
mediated by NO self inhibition of NOS, the presence of co-factors and the level of 
Ca2+ ions. The relevance of Ca2+ is explained by the action of calmodulin. Calmodulin, 
the first identified co-factor for NOS only binds to NOS at high concentrations of Ca2+ 
and is responsible for the facilitation of electron transfer from the reductase domain to 
the haem domain in the protein. This is required for the catalytic conversion of L-
arginine to L-citrulline. As was previously mentioned, the necessary levels of Ca2+ vary 
between isoforms, with iNOS requiring the least amount of Ca2+ to produce NO as a by-
product of the aforementioned reaction.(D.S. Bredt & Snyder, n d),(Gachhui et al., 
1996) eNOS is highly sensitive to Ca2+ and is in fact transiently activated by a large 
variety of cellular signals such as receptor binding, cell-wall stress and even blood 
pressure.(Amano, 2002) NO is also responsible for NOS regulation as part of a 
feedback loop. NO has been found to block the site of catalytic conversion by reacting 
with the surrounding area to form one of its many highly reactive by-products.(Boucher, 
Moali, & Tenu, 1999) 
 
1.6.2 Genetic engineering of Nitric Oxide Synthases 
 
The genetic modification of NOS for research purposes has received surprising little 
attention. To date, several point mutations have been induced to further elucidate its 
function and determine which amino acid groups are vital to its function. Using these 
methods, it has been found that mutation of the serine 1177 residue of eNOS attenuates 
phosphorylation of the protein and reduces its activity.(Dimmeler, Fleming, et al., 1999) 
Another example can be found in the work of Robinson and Michel whereby the 
involvement of cysteines 15 and 26 were found to be vital in the palmitoylation of 
eNOS.(Robinson & T. Michel, 1995) Other approaches involve altering the level of 
NOS expression and thus raising the production of NO to higher levels. Kader et al 
(Kader et al., 2000) studied the effect of NOS overexpression on platelet aggregation 
and smooth muscle cell proliferation. 
To date however, chimeric forms of NOS have not been created. The potential 
application for novel NOS proteins are varied, with the possibility of commercial and 
medical  uses, as NO plays a vital role in various physiological processes in numerous 
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organisms. See section 1.5 of the literature review for the role of NO in physiological 
processes. 
In order to create functional chimeric NOS, it is vital to preserve the oxygenase 
domain where the catalytic conversion of L-arginine to L-citrulline takes place. This 
phenomenon is observed in bacterial NOS which have been found to contain only an 
oxygenase domain. It is hypothesized that the reduction function is carried out by other 
proteins found in bacteria and therefore the reductase domain becomes obsolete.(Gosh 
& Salerno, 2003) It is further hypothesized that the reduction events of the redox chain 
necessary to form eNOS in these life forms are carried out by other proteins, such as 
flavodoxins or ferredoxins.(Gosh & Salerno, 2003) Due to this, the majority of genetic 
alterations proposed towards the creation of chimeric NOS will focus on the reductase 
domain of the protein. 
One of the few transgenic NOS cell lines created was developed by Kaur et al.(Kaur 
et al., 2009) The group transfected human endothelial progenitor cells with eNOS 
accompanied by a reporter system. The cell line was transfected using a lipofectamine 
method of mammalian transfection. This method relies on encasing plasmids in 
liposomes to facilitate their uptake by cells. The resulting strain was shown to produce 
higher levels of NO, demonstrated by increased nitrite concentration in the solution. 
The strategy included a GFP reporter, which was used to estimate transfection 
efficiency. Cells were plated at equal densities in plates containing fibronectin (an 
extracellular matrix protein) to promote adhesion. Transfected cells showed a 35-40% 
increase in eNOS expression compared to untransfected cells. The ability of cells to 
form spindle like structures was then assessed and the eNOS transfected cells were 
shown to exhibit a marked increase in cells displaying the mature morphology. Cells 
containing transfected eNOS but lacking the GFP marker proved to be the faster 
developing strain as demonstrated by confocal microscopy, with both samples showing 
an increase in maturation over the control untransfected cells.  This elegant experiment 
served to establish the hypothesis that transgenic forms of eNOS can be used to treat 
certain ailments such as CAD (coronary heart disease).(Kaur et al., 2009) Patients with 
CAD exhibited reduced endothelial progenitor cell maturation and the cellular 
transplantation which could be possible with cells such as those developed by the 
Kartha group may work to attenuate damage caused by myocardial ischaemia (Kaur et 
al., 2009). Endothelial progenitor cells have recently been implicated in the reparation 
of the endothelial monolayer.  
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Another field in NO research has been the creation of transgenic mice for the 
purpose of studying NO function in physiology. The majority of these involve the 
creation of knock out mice which either lack an NOS altogether or contain a loss of 
function mutation. The findings presented in such studies are invaluable as they 
demonstrate the ubiquity of NO signalling as well as determining physiological roles of 
the NOS's and NO itself. An example of such research can be found in the work of 
Mrowka et al where the effect of NO on arterial blood pressure was studied.(Stauss, 
Nafz, Mrowka, & Persson, 2000) 
It is important to note that not all work directly pertaining to the study of NOS 
involves genetic engineering. In one chemical approach, a compound containing a 
chromophore analogous to NADPH was developed to replace NADPH binding, creating 
a photosensitive NOS.(Beaumont et al., 2008)  This compound named Nanotrigger was 
designed so that only when light of a specific wavelength shines on the proteins, nitric 
oxide is released which can subsequently be detected by an electrode. In the absence of 
light incidence, the Nanotriggers block NADPH binding sites without undergoing 
reduction. However upon subsequent incidence of light the reduction reaction is 
initiated. Slama-Schwok et al have verified that the compound causes eNOS to produce 
NO in response to light.(Lambry, Beaumont, Tarus, Blanchard-Desce, & Slama-
Schwok, 2009) This work could be used as a novel, dependable method to test NO 
inhibitors or as a tool for researchers working on processes involving NO and its by-
products.  
 
 
1.6.3 Cellular NOS 
 
Nitric Oxide Synthases are present in a large variety of cell types as NO is a highly 
versatile intra and inter-cellular messenger. More than one isoform may be present in a 
cell type and information regarding the presence/absence of NOS isoforms in a cell line 
is crucial when attempting cell-engineered NO strategies. 
The work of Tullio et al demonstrated that CHO-K1 cells are capable of expressing 
the nNOS and eNOS isoforms of NOS.(Florio et al., 2003) This result was obtained via 
northern blot, a technique demonstrating the presence of specific RNA sequences in 
cells which are demonstrative of active protein expression.  
The body of work depicted in the literature demonstrates that the insertion of eNOS 
to various cell lines is possible, with non-lethal effects and detectable by a large variety 
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of methods. The findings show that insertion of the eNOS gene has been used for 
characterization of the protein, elucidation of some of its interactions and many of its 
effects. 
eNOS has been transfected into various cell lines. These include muscle cells, COS-
7 and CHO-K1.  COS-7 (CV-1(Simian) in Origin SV-40+) cells were transfected with 
eNOS using a DEAE-dextran-chloroquine protocol with the purpose of further 
characterizing eNOS and a transient cell line was obtained. In this work, transfected 
cells were combined with the A23187 calcium ionophore to demonstrate enhanced 
eNOS activity in cells. This provided evidence as to the dependence of eNOS on 
calcium concentrations for protein activity (S Lamas, P. a Marsden, G. K. Li, Tempst, & 
T Michel, 1992). The study utilised cGMP measurements as a method of quantifying 
NO production. 
 The transfection of smooth muscle cells with eNOS has been described in the work 
of Sato et al.(J. Sato et al., 2000) In this work, cells were transfected using a 
Lipofectamine protocol and the effect of transfection was monitored and analyzed. The 
findings from the study demonstrated a decrease in cell proliferation combined with an 
increase in p17 and p21. It was also found that the expression of the constitutively 
active NOS isoform eNOS did not cause an increase in cellular apoptosis over a time-
frame of 72 hours. Another example involves the transfection of vascular smooth 
muscle cells. This can be found in the work of Gurjar et al.(Gurjar, R. V. Sharma, & 
Bhalla, 1999) The study demonstrated the inhibitory effect of eNOS produced NO on 
the metalloproteases MMP-2 and MMP-9, which are relevant towards cellular migration 
after injury. In this work, a wild type cell line was used as a control and an additional 
control involving transfection of cells with GFP was used to verify that it was not the 
transfection procedure which elicited a response. The involvement of NO was 
conclusively demonstrated by rescuing the wild type phenotype by use of an eNOS 
inhibitor and thereby restoring cellular migratory capability. 
An example where CHO-K1 cells were transfected with eNOS can be found in the 
work of Noiri et al.(Noiri, 2002) In this case, the intent was to characterize a missense 
mutation in eNOS (Glu298Asp) and its association with Renal disease. The reason 
behind the group's interest in this mutation was due to its frequent occurrence in patients 
exhibiting end-stage renal disease. Cells were transfected with mutant and wild type 
eNOS. The method used to detect NO was an indirect one, measuring Nitrite 
accumulation via the fluorescent interaction of 2,3-diaminonaphtalene with nitrite. The 
data demonstrated a dramatic decrease in cellular nitrite production in the mutant cell 
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line, indicating that a deficiency in eNOS produced NO is in fact linked to end-stage 
renal disease. 
In some cases, eNOS transfections were utilized to re-introduce the protein to 
knock-out organisms. One such example can be found in the work of Feron et al, where 
this approach was taken to elucidate the interaction between Caveolin-1 and 
eNOS.(Feron & Balligand, 2006) In this case, neonatal cardiomyocites were used and 
cells were transfected with both wild type eNOS and a variation containing a mutation 
which removes its myristoylation site. The findings support a strong interaction between 
the two proteins and propose Caveolin-1 to be a strong antagonist to NO production as 
eNOS activity was shown to dramatically increase in the absence of Caveolin-1. 
 
 
1.7 Chemical Inducers of Dimerization 
 
Chemical inducers of dimerization (CIDs) are a relatively recent development in the 
field of biomolecular engineering. It involves the use of an agent to trigger binding of 
two targets, bringing the targets within functional distance of each other. The principle 
of this system requires compounds that have the ability to bind to two different protein 
domains. By tagging proteins with the domains that bind to the compound, the proteins 
come within close enough proximity to bind to each other and thereby create a dimer. 
Several proteins function as homo/heterodimers and this technique allows inducible 
dimerization. In addition CID can also be used to catalyze protein activity for proteins 
that require dimer formation. 
An example of a CID system can be found in the work of Crabtree et al.(Belshaw, 
Spencer, Crabtree, & S L Schreiber, 1996) In this study the group used the 
immunosuppressant cyclosporin A to create a CID system which would bind a chimeric 
protein containing a cyclophilin domain and a cytoplasmic signalling domain of FAS. 
To achieve this, (CSA)2 was synthesized from cyclosporin and the signalling domain of 
FAS was fused to a cyclophilin. This allowed the creation of homodimers upon 
introduction of CSA to the system. When CSA is introduced, two cyclophylin 
molecules bind to CSA, bringing the fused FAS domains close together and thereby 
creating a functional homodimer. The design resulted in the induction of apoptosis upon 
dimer formation. 
An alternate approach was taken by Hu et al.(Kopytek, Standaert, Dyer, & Hu, 
2000) In this work, the group focused on the immunosuppressant bis-methroxate and its 
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ability to dimerize dihydrofolate reductase (DHFR). To construct this CID system, the 
group synthesized bis-methroxate and assayed its ability to dimerize DHFR via gel-
filtration analysis of the purified protein. They found a complex corresponding to 
double the molecular weight of the monomer (suggesting dimer formation) and 
discovered that the off-rate of the complex was approximately one hundred times slower 
than the wild type dimer. This suggested that the bisMTX/DHFR2 complex is capable 
of creating more energy favourable conditions for protein interaction than the wild type 
dimer. 
Many CID systems rely on compounds which are known to have 
immunosuppressant qualities. In both the described examples, the chemical responsible 
for the formation of dimers is a type of immunosuppressant.  Another example of CID 
systems is that based on rapamycin/Frb/FKBP12. Unlike the two systems mentioned 
previously, the rapamycin utilizes three components rather than two. The system works 
by sequential binding of the two protein domains to rapamycin. FKBP12 (part of the 
mTOR gene) is known to interact directly with Rapamycin, whereas Frb (the FKBP12 
binding domain of the FRAP protein) only binds to the Rapamycin/FKBP12 complex, 
Figure 13. (Drenan, Xiangyu Liu, Bertram, & Zheng, 2004) 
 
 
Figure 13 An illustration of the Rapamycin CID system and the sequential binding 
between Rapamycin 0.91 kDa, FKBP12 12.6 kDa and Frb 11 kDa. 
 
Frb Rapamycin FKBP12 
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The cytotoxicity of many of the compounds used for the creation of CID systems 
limits their application to mutants where the cytotoxic activity of the compound is 
abolished. For example, rapamycin is known to arrest yeast cells in G1 of the cell 
cycle.(Heitman, Movva, & Hall, 1991) Alternatively construction of analogues of these 
cytotoxic compounds could reduce or remove their inherent toxicity.  
 
1.8 Photoactive Sensors 
 
Recent and continuous advances in both ability to detect/process light-based signals 
and genetic engineering have lead to the creation of the emerging field of photoactive 
sensors. Such sensors generally emit or absorb light so as to create a signal to be 
detected in response to the target analyte. Unlike previously described sensors such as 
the LAPS system, these utilize naturally occurring proteins or chemically derived 
polymers which can either emit light when they come in contact with the analyte or 
alternatively absorb light to excite a component and create a chemical or electrical 
signal.  
 
Figure 14 The genetic circuit for edge detection Adapted from Tabor et al (Tabor et 
al., 2009). A: The Dark Sensor component works by incorporating a chimeric cph8 
gene which requires the interaction of pcyA and ho1 gene product (PCB) to 
phosphorylate the response regulator OmpR, which in turn binds to the PompC 
promoter and continues the circuit to the X AND (NOT Y) gate. The light sensitive 
switch is within the cph8 chimeric protein, which is sensitive to red light in a 
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manner which prevents the phosphorylation reaction when light is present. If light 
is not present, the circuit is continued and allows the expression of luxL (a quorum 
sensing gene from V. fischeri  responsible for the production of AHL) and cI (a 
repressor of transcription) are expressed (Egland & Greenberg, 1999). The product 
of luxL activates transcription under the P-luxλ promoter whilst the product of cI 
represses this transcription event. Due to this, when X is present and Y is absent 
higher transcription levels of the subsequent gene in the circuit - lacZ would be 
expected. This in turn would lead to the production of pigment by the cleaving 
action of lacZ on the sugar β-galactosidase. B: 1) Mask. 2) Cell culture expressing 
lacZ directly under a light sensitive promoter. 3) Cell culture with the edge 
detection gene circuit. C shows darker pigment on the edge of light detection 
rather than on the parts which are not illuminated.(Tabor et al., 2009) 
 
One of the most commonly utilized light emitting proteins in research is GFP. 
Isolated from Aequorea victoria, this protein fluoresces at a wavelength of 398 nm and 
is often used as a reporter in experiments relating to protein expression.(Gorokhovatsky 
et al., 2004),(Motoike et al., 2000) In such studies, the GFP protein is fused to the 
protein being expressed so as to form a direct relationship between the levels of 
expressed protein and intensity of fluorescence.(Motoike et al., 2000) This simple and 
efficient method has led to a better understanding of promoters and terminators leading 
to the optimization of expression systems.  
An elegant example of genetic engineering to create a cellular photo-detector was 
pioneered by Voigt(Levskaya et al., 2005) and Ellington.(Tabor et al., 2009) By 
creating cells which repress pigment production upon light incidence, and using simple 
masks it was possible to replicate an image onto a bacterial plate, Figure 14. However 
as the system is reliant on photoactivation of transcription machinery, it takes several 
hours for the cells to produce the pigment with continuous exposure to light. In 
addition, the process is irreversible meaning that only one image may be formed on a 
bacterial plate. Therefore the system, although innovative, is still inferior to 
conventional methods of photography and must be further adapted to become anything 
more than proof of concept.In order to truly harness the potential of cellular photo-
detectors, the photon detecting system must be incorporated into protein activation 
rather than transcription coupled. By using this method, the reporting of light incidence 
can be reduced in time from hours to seconds or potentially milliseconds, depending on 
the activity of the target protein. To achieve this, the system must be designed so as to 
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produce a molecule detectable by the electrode specifications (i.e. size, charge, 
necessary concentration) whilst keeping in mind the effect the signalling molecule 
would have on the cell. There are many proteins which are light sensitive, as previously 
described, but the cascade these proteins trigger is not necessarily one which is optimal 
for electrode detection. To circumvent this, many approaches can be taken, each with its 
set of benefits and disadvantages. A down-stream element in the cascade of protein 
activation may be detectable. However, whilst preserving the integrity of the system this 
causes a delay in the signal and depending on the detector system involved may not be 
feasible. Approaches such as the creation of AND, OR or NOR gates so as to link 
expression of one gene to the activation of another shares the advantages/disadvantages 
previously delineated. Creating a chimeric fusion protein which will act as both detector 
and imitator of signal would lead to the highest rate of signal delivery, but could 
severely compromise protein function, reducing or even abolishing protein activity. 
 
1.9 Optogenetics 
 
Optogenetics is an area of genetic engineering which focuses on creating cellular 
responses to light.(Deisseroth, 2011) A large proportion of these approaches rely on 
opto-activated gene transcription/translation through various mechanisms such as the 
use of light-activated ligands, light-triggered cascade events and the use of chimeric 
fusion proteins involving light-activated domains. 
One major family of light-sensitive switch proteins used in this field are opsins. 
Members of this family include bacteriorhodopsin and channel rhodopsin. The 
advantage of using light dependent activation for cellular processes is the ease with 
which the system can be activated/inactivated and the specificity which can be 
conferred. Practical applications of optogenetics have quickly developed to the stage 
where the degree of complexity is high. This is due to the possibility of targeting 
specific cell types, activation with light of a specific wavelength and a possible response 
time in the order of milliseconds. 
Peng et al have developed a system that achieves insulin expression as a result of 
blue light stimuli.(H. Ye, Daoud-El Baba, Peng, & Fussenegger, 2011) This was 
accomplished by introducing melanopsin into a cell line, which when combined with a 
G-protein coupled receptor caused a signalling cascade in turn activating an inserted 
trans-gene expression. The system was tested in vivo and the chosen trans-gene was an 
insulin encoding one. Mice were treated with encapsulated mutant cells and exposed 
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intra-corporeally to blue light for a period of 48 hours. This invasive procedure was 
achieved using optical fibres to deliver light at the correct wavelength with sufficient 
intensity. The results showed that mice with the micro-encapsulated cells, both those 
suffering from diabetes and wild type, showed an increased level of insulin in the blood, 
signifying successful trans-gene activation.(H. Ye et al., 2011) By replacing the insulin 
gene with any other product, it would theoretically be possible to express any protein in 
a similar fashion.  
Gene level optogenetic systems, suffer time-lapse related issues. As the  majority of 
optogenetic systems rely on light-dependent gene transcription, the response rate is 
limited by the native cell-machinery in as far as producing the target protein. This 
causes a time lag between stimuli and response in the order of several hours. For some 
applications, i.e. insulin production in diabetics this would probably be a favourable 
trait, but for many other systems it would be detrimental. One method of bridging this 
gap would be to create photo-activable proteins which would become directly photo-
stimulated, or designing a signalling cascade that would have an effect on a protein 
level rather than a gene level. A possible method of achieving this would be via protein 
phosphorylation. By initiating a cascade that would cause the activation of a kinase or 
phosphorylase which could target the protein of interest it would be possible to severely 
decrease the response-time and thus improve the efficacy of the desired effect. 
Another innovative application derived from optogenetic engineering is described in 
the work of Erica Pastrana.93 The system described was designed so as to modulate 
neuronal activation via a light-dependant change of membrane potential. To achieve this 
effect, channelrhodopsin2 was used in conjunction with NpHR and Arch to control the 
flow of ions through the cell membrane. Illumination of Chr2 with blue light (470 nm) 
causes an influx of Na+ and Ca2+ ions and an outflow of K+ ions. Illumination of NpHR 
with orange light (589 nm) would lead to an influx of Cl- whereas light at 575nm would 
activate Arch so as to cause an efflux of H+. By using all three in conjunction it is 
possible to modulate membrane potential behaviour. Shining blue light would result in a 
rapid accumulation of positively charged ions whilst yellow or orange light would result 
in the induction of a negative charge via the influx of Cl- ions (NpHR) and an outflow 
of H+ ions (Arch) respectively. By not allowing the cell to accumulate sufficient 
positive potential to permit a trigger event, the activating potential threshold is never 
reached and therefore response is attenuated. Thus exposure to all light wavelengths 
would result in no effect caused by the system and the presence of an isolated 
wavelength of light (470 nm) the system is activated.(Pastrana, 2010) 
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The two systems described above demonstrate both the transcription/translation use 
of optogenetics and the photoactivated protein approach to create malleable, responsive 
and selective systems with potential technological applications. Although there are 
several advantages to the photoactivated protein approach of optogenetics, its major 
drawback is that it is severely limited in potential applications. This limitation is derived 
from the fact that photoactive proteins only produce limited functions such as ion 
channel activation in the case of opsins and electron transfer to a flavin mononucleotide 
in the case of LOV (Light Oxygen Voltage domains). Although these can be harnessed 
to produce a desirable function, there is an issue of the compatibility of these 
mechanisms with the target operation. The gene transcription/translation method offers 
much more varied application possibilities as the system can be tailored to act on 
different target genes. In essence, the protein tool-kits available to construct optogenetic 
systems are far more limited than the genetic equivalent. 
As a follow up to the previously described optogenically controlled neurone 
activation/inactivation strategy, Deisseroth et al also constructed a rhodopsin-GPCR 
chimera (OptoXR) that responded to green light.(Deisseroth, 2011) GPRCs are capable 
of producing protein cascades therefore they have potential applications in more 
complex systems. An exemplary application of the OptoXR system involves neuronal 
biochemical pathways.  Neurones are as a family capable of using GPCR activation as a 
form of intracellular communication via the serotonergic, dopaminergic and adrenergic 
pathways as well as via a downstream cascade of neurotransmitters such as Gaba and 
glutamate. It is therefore thought that by integrating Opto-XRs it will be possible to 
manipulate neuronal signalling in a spatio-temporal controlled manner. These light-
activated proteins work on an extremely fast time-scale which varies between proteins 
ranging from approximately 4 milliseconds to almost 30 minutes. It is noteworthy that 
the majority of these proteins work on a millisecond scale. 
 
1.10 LOV 
 
LOV (Light Oxygen Voltage) domains are a part of the phototropin family of 
proteins. These proteins are thought to be vital for the common process found in many 
plants denominated phototropism, the bending of the plant stem so as to maximize light 
exposure. This occurs by the de-synchronized growth of cells, with cells growing faster 
on the side exposed to light and slower on the side exposed to darkness, causing a bend 
in the stem and increasing the plant surface area exposed to sunlight. This class of 
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photoactive protein has absorption ranges in the UV-A/blue light range and is involved 
in a large variety of plant cell behaviours, among them leaf positioning.(Iino, 
2006),(Inoue, T. Kinoshita, Takemiya, M. Doi, & K. Shimazaki, 2008) The protein 
autophosphorylates under light incidence and is involved in other processes such as 
stomatal opening and chloroplast migration. Phototropins are vital for plant life and the 
appropriate physiological responses allowing natural cycles such as photosynthesis and 
the Krebs cycle to occur.(Toshinori Kinoshita et al., 2001),(Volkov & Ranatunga, 2006) 
LOV domains were originally discovered in the 120 kDa protein NPH1 bBlue light 
receptor phototropin) which is an autophosphorylating kinase which depends on 
UVA/blue light as its inducer. The phototropin sub-group family LOV contains two 
members: LOV-1 and LOV-2, each with an approximate molecular weight of 12 
kDa.(Volkov & Ranatunga, 2006) Both proteins bind to the same chromophore and 
both bind to flavin mononucleotides (FMN). The binding process can occur in darkness 
and has a maximal absorption peak of 447 nm whilst when occurring in light it has an 
absorption peak of 385 nm.(Cho et al., 2007) The interaction between LOV proteins 
and FMN is thought to be derived from the proximity of a reactive cysteine from LOV 
(cys 62) to the isoalloxazine ring moiety of the flavin molecule. The covalent chemical 
bond formed by the cysteinyl-flavinoid complex occurs within microseconds of light 
exposure.(Winslow R. Briggs et al., 2007)(Möglich, R. Ayers, & Moffat, 2009)In 
effect, this means that in dark conditions, LOV binds to FMN non-covalently, but upon 
light incidence a covalent bond is formed.(Michael Salomon et al., 2001) The dark state 
shows an absorption peak at 447 nm and upon incidence of blue light the LOV-Flavin 
complex forms an intermediate state with an adsorption peak of 715 nm and transitions 
to the signalling state with an adsorption peak of 385 nm. The protein therefore cycles 
between an inactive state (447 nm) and an active one (385 nm) depending on the 
absence/presence of light. This effect is presumed to be due to the interaction between 
the C(4a) carbon in FMN and the cysteine 39 residue from LOV.(Zenichowski, Gothe, 
& Saalfrank, 2007) Mutation of the LOV cysteine 39 residue into alanine or serine 
results in a loss of protein photoactivity, further proving its involvement in the 
photochemical process described.(Michael Salomon, John M Christie, Knieb, Lempert, 
& Winslow R Briggs, 2000) 
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Figure 15 The structure of LOV1/2 domains. Obtained by fusing PDB files 2Z6D 
(LOV1) and 1JNU (LOV2) as the complete protein structure has not yet been 
elucidated. Fusion was performed by attaching N terminus of 2Z6D to the C 
terminus of 1JNU.  The selected colourscheme corresponds to location of the 
structure in relation to N or C terminus. The colourscheme goes from blue (N 
terminus) to red (C terminus). 
 
In nature, the LOV-2 gene is thought to act as a photoactivable switch used to turn 
on a kinase pathway found in phototropin. In vitro studies of LOV-2 activation in the 
phototropin gene phot2 have indeed shown LOV-2 to act in a manner showing a dark-
state repressor of phot2 PKA kinase of the PAS family.(Matsuoka, Iwata, Zikihara, 
Kandori, & Tokutomi, 2007)   
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Figure 16 The LOV1-FMN interaction cycle upon blue light incidence. Shown are 
the dark stage (educt) and light stage (adduct) with the transitory triplet stage in 
between. Adapted from Zenichowski et al (Zenichowski et al., 2007) 
 
LOV has attracted much attention due to its relatively small size and its inducible 
functions. The roles of analogues of the LOV proteins found in bacteria are currently 
unknown. It is proposed that they may act as photoreceptors involved in phototaxis, 
regulation of DNA expression and in some cases play a part in photosynthetic 
machinery.(Crosson, Rajagopal, & Moffat, 2003) LOV domains are recognized as 
targets for optogenetics, the engineering of genetic systems so as to render them light 
activable/inducible and therefore create systems which will alter the cellular behaviour 
upon incidence of light. (Pastrana, 2010) 
LOV is becoming prominent in the realm of light activable proteins. Its affinity to 
FMN has been further studied by the work of Briggs et al whereby using LOV fused to 
CBP (calmodulin binding protein) to enhance purification of the protein using a 
calmodulin resin affinity chromatography.(J M Christie, M Salomon, Nozue, M Wada, 
& W R Briggs, 1999) The mutant exhibited a slightly shifted absorption spectrum, 
thought to be caused by the fused CBP domain. This finding demonstrates the fact that 
proteins may behave differently when fused to other domains. Although in this case the 
shift in absorption spectrum is a minor issue, in other systems this could prove 
problematic depending on the intended application of the fusion protein. 
The exploitation of the photo-activable mechanism of LOV is in its emerging stages. 
Work by Moffat et al allowed the creation of a LOV/Kinase fusion protein which 
became light inactivated.(Möglich et al., 2009) This was demonstrated by measuring 
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levels of phosphorylated FixJ, a target of the Ytva kinase. In this work it was 
demonstrated that, in effect, it was possible to abolish Ytva activity upon light incidence 
by using a fused Ytva-LOV construct. It is important to note that Ytva is naturally 
inactivated by the its signalling molecule, meaning that the abolishment of protein 
activity demonstrates a successful signalling event. The vast majority of proteins which 
are light sensitive show increased protein activity upon light incidence, rendering this 
study useful for specific applications regarding protein inactivation.(Möglich et al., 
2009) Unfortunately, as in the case of nature, most applications involving photo-
activable sensors desire the opposite result. 
 
1.11 Aims and Objectives: 
 
Research within this thesis aims to design and construct a cell based device capable 
of converting an external stimulus (either chemical or optical) into a measurable output 
for the eventual integration with electronics. This system involves mutating the NO 
producing gene eNOS to output NO in response to a specified stimulus. Signal 
transduction will be achieved via the use of an amperometric sensor capable of 
detecting nitric oxide and thereby creating a suitable bio-electro interface. In this way it 
will be possible to create an artificial signal transduction pathway (opto-chemi-electro) 
as well as a reporter/detector system capable of producing an electrical output in 
response to a selected chemical input. To implement the chemically responsive strategy, 
the FKBP12/FRAP/rapamycin system is proposed, whereby the eNOS protein is 
separated according to domain and attached by a linker to the relevant region of the 
FKBP12 gene and the FRB domain of the FRAP protein. In the presence of rapamycin, 
these proteins should bind and bring the chimeric eNOS fragments close enough 
together to bring the domains within functional distance, allowing the production of 
NO.. This system can potentially be modified to respond to a variety of stimuli and 
allows detection within seconds of exposure, providing a real time quantitative signal 
regarding the presence of an agent. This can in turn be developed into an array capable 
of detecting the presence of a variety of analytes from a single population of cells. 
Photoactivation of eNOS will be attempted via appropriate genetic modification of the 
eNOS gene via insertion of the LOV domains. The LOV strategy will require the 
insertion of single or multiple copies of the LOV gene into the eNOS protein. The LOV 
will bind to FMN within the protein and upon incidence of light at 385 nm wavelength, 
electron transfer will occur between the photoactivated LOV to the FMN molecule. 
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Using the naturally occurring electron transfer pathway of eNOS, the electron should 
travel across the co-factors in the ET pathway and finally be used to reduce citrulline 
and produce the NO as a by-product. Ultimately, the NADPH binding site of eNOS will 
be mutated to create a loss of function mutation. Without the NADPH binding event to 
generate electron transfer, the protein will depend on photoactivation to produce NO, 
removing the necessity of a chemical substrate and reducing signal interference.  
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Chapter 2 Materials and Methods 
 
2.1 Materials and apparatus 
Sigma-Aldrich: DAF-2 DA, DAPI, Rhodamine Phalloidin, Nafion 117, NiTSPc, NaOH, 
CuCl2, Kanamycin,  
NaCl, Bacto Peptone, EDTA, L-NNA, L-NMMA, 7NI 
Syngene: UV-Transilluminator 
Riedel de Haen: HCl 
Nanodrop: Spectrophotometer for DNA sample concentration detection 
Labconco: Refrigerated Centrivap Concentrator 
Jennway: pH meter 
ATCC: CHO-K1 cell line, pEX_EF1_CFP-NOS3 plasmid 
Addgene: pBABE-TetCMV-puro-mVenus-LOV plasmid 
Ascent Scientific: SNAP 
Promega: DNTP's 
Fermentas: EcoRI, Buffer B Pink 
Epicenter: T5 exonuclease 
NEB: Phusion Polymerase, Phusion buffer, Taq Polymerase, Taq buffer, HpaI, NheI, 
AccI, NotI. T4 DNA ligase 
Invitrogen: Opti-MEM media, Lipofectamine LTX with Plus Reagent  
Fisherbrand: Pipettes, Pipette Boy, Gloves. 
Eppendorf: Universal tubes (1.5 mL) 
Greiner Bio-One: 50 mL Falcon tubes. 
ITDNA: Primers 
Major Science: Potentiostat for electrophoresis. 
Biometra: Tanks used for electrophoresis. 
BD Biosciences: FACSCANTO II flow cytometer 
Leica: Fluorescence Microscope 
BASi: Platinum Electrode, Aluminium oxide slurry, Silver/Silver Chloride electrode, 
microcloth polishing pad 
Ivium: Ivium Compactstat potentiostat  
Gibco: HBSS, PBS, DMEM, Penicillin Streptomycin, Glutamate, Trypsin  
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2.2 Cell Handling 
 
2.2.1 Medium 
In order to ensure replication and survival cells require specific nutrients within the 
growth environment, however the exact requirements for favourable growth and 
division differ between organisms and cell types. For mammalian cells such as CHO-
K1, commercially available DMEM medium supplemented with 10% FCS, 1% 
glutamate and 1% penicillin streptomycin was used. 
      To obtain an agar gel for bacterial plates, 2% agar is added to the mixture prior 
to the autoclaving step. It is important not to let the gel set before plating occurs. When 
adding antibiotics to screen for resistance (selective markers), these should be added 
after the solution has reached a temperature of less than 60 °C. SOB medium is a 
nutrient rich broth used to grow bacteria after cell damaging processes such as 
electroporation. 1 L of SOB is prepared from bacto-tryptone (30 g), bacterial yeast 
extract (5 g), NaCl (0.5 g) and KCl (2.5 mL, 1M) with the remaining volume (up to 1L) 
composed of ultrapure water.(S. J. Lee et al., 2000) The media is autoclaved prior to 
use. LB medium is widely used to culture bacteria such as E.coli and is composed of 
tryptone (10 g), yeast extract (5 g) and NaCl (10 g) to which water (800 mL) is added 
and the volume topped up to 1 L. The solution must be autoclaved before 
use.(Anderson, 1946) 
 
2.2.2 Strains and Cell Lines 
 
Mammalian cells (Chinese Hamster Ovary cell, K1 strain) were purchased from 
ATCC, USA. For the purposes of this project, only two strains of micro-organism were 
required: 
• E.coli TOP 10, a strain of E.coli with reduced infectivity (generously donated by 
the Chris Voigt Laboratory, UCSF, USA). 
• JM109 cells, a strain of E.coli with reduced infectivity and high transformation 
efficiency. Obtained from promega. 
 
2.2.3 Master Colonies 
 
Plate grown bacterial cells were selected and removed using a toothpick. The 
toothpick was placed in a vial containing growth medium (10 mL, LB) and cells left to 
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grow overnight to an OD600 of 3-6 followed by centrifugation at 3700 rpm for 10 
minutes. Supernatant was removed and fresh medium added along with glycerol to a 
total concentration of 20-30% of solution. The sample was then placed in a cryotube 
and stored in a freezer at -80 °C. 
Mammalian CHO-K1 cells were grown in DMEM supplemented with 10% FCS and 
1% penicillin streptomycin and 1% Glutamate and incubated at 37 °C and 5% CO2 to a 
confluency of approximately 80%. Cells were washed in PBS/HBSS (2 mL) to remove 
serum and phenol red and then underwent trypsin treatment to detach adhered cells. 
This was achieved using a 1:1 ratio of trypsin and PBS/HBSS and centrifuged (1400 
rpm) to form a pellet which was resuspended in DMEM supplemented with 20% FCS 
and 7.5% DMSO. The cell suspension was then placed into appropriate cryotubes which 
were inserted to an isopropanol "nest" and stored at -80 °C for 2-3 days followed by 
subsequent storage in liquid nitrogen until required.  
 
2.2.4 Transfection of CHO-K1 Cells 
 
Mammalian cells cannot undergo the transformation procedures endured by bacterial 
or yeast cells due to their intricate nature, therefore a different method must be 
undertaken to successfully transfect these cell lines with the plasmid of interest. One of 
the more efficient methods of transfecting mammalian cells is Lipofection, whereby the 
plasmid of interest is encased in liposomes which then fuse to the cell membrane 
encouraging uptake of the plasmid DNA by the cells. Transfection was carried out 
according to the following protocol. The day prior to transfection, cells were 
trypsinized, counted and plated in a 24-well plate at a concentration of 4 x 104 cells per 
0.5 mL of growth medium. Cell density at the time of transfection was targeted at 50-
80% confluency. A solution of plasmid DNA (0.5 μg, 100 ng/μL per well) was prepared 
in Opti-MEM reduced Serum media (100 μL, Invitrogen, UK) with no extra serum 
added. The solution was then treated with Lipofectamine LTX (1.5 μL) per well and the 
resulting mixture incubated for 25 minutes at room temperature to allow the formation 
of DNA-Lipofectamine LTX complexes. Old media was removed from the cells and 
replaced with fresh growth medium. Each well containing cells was then treated directly 
with the DNA-Lipofectamine LTX complex solution (100 μL) and mixed by gentle 
rocking of the plate back and forth. Cells were then incubated for 24 hours at 37 ºC at 
5% CO2 prior to addition of marker antibiotic. 
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The incubation period described in the final step is necessary to allow expression of 
the antibiotic resistance conferred by the plasmid of interest, which is essential to the 
formation of “stable” expression lines. In the majority of cases the plasmid of interest 
will be non-essential and display transient expression with the plasmid dropping out of 
cell culture over time, with subsequent loss of gene expression. It is therefore desirable 
for plasmids to contain antibiotic resistance to ensure their continued presence within 
transfected cell lines. 
 
2.2.5 CHO-K1 Geneticin Kill Curve 
 
In order to confirm the presence of the correct DNA sequences in transformed cells, 
transformed cell lines were subjected to a geneticin (G418) kill curve. Transformed and 
untransformed cells were grown in a 24 well plate with 1 mL medium containing the 
following G418 concentrations: 5 mg/mL, 1 mg/mL, 0.8 mg/mL and 0.4 mg/mL. Due to 
the highly variable concentrations demonstrated in literature for the G418 dosage of 
cells and the acting mechanism of G418, it was necessary to construct a kill curve 
specific to the cell line of interest. Cells were then left to grow for 1 week, medium 
changed every 3 days (maintaining the antibiotic concentration between changes) and 
following this course of antibiotics the wells were observed under a microscope. The 
aim of these experiments was to determine the concentration of G418 necessary to kill 
untransfected cells whilst maintaining the viability of transformed cells.  
 
2.2.6 Staining with DAF-2 DA 
 
DAF-2 DA allows for fluorescent staining of nitric oxide in cells. The staining agent 
is cell-wall permeable and allows visualization of localized nitric oxide production 
within the cell using fluorescent microscopy. Like many fluorescent staining agents, 
DAF-2 DA is extremely light sensitive and all work with DAF-2 DA was conducted in 
low-light environments. Cell staining was carried out according to the following 
protocol. The day prior to staining, cells were trypsinized and counted. Cells were 
plated in a 6-well plate containing a coverslip at a concentration of 4 x 104 cells per 0.5 
mL of growth medium. Cells were then incubated at 37 ºC at 5% CO2 overnight. Cells 
were washed with PBS prior to staining to remove BSA, phenol red or any such 
compounds present in media which could interfere with the fluorescent dye. A working 
solution of DAF-2 DA was achieved via dilution. PBS was removed and 1 mL of the 
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diluted DAF-2 DA solution added. Cells in the staining solution were then incubated at 
room temperature for 30-40 minutes. The solution was then aspirated and the sample 
washed with PBS to remove excess fluorophore. Samples were kept in PBS after the 
wash in the previous step until required for imaging which was performed immediately 
after staining due to the lack of the paraformaldehyde fixing step. The coverslip was 
removed using tweezers and then placed on a microscope slide, sample side facing 
downwards and imaged under a fluorescent microscope. 
 
2.2.7 Staining with Rhodamine Phalloidin/DAPI 
 
Rhodamine phalloidin is a fluorescent compound which binds to the actin 
cytoskeleton in cells. This allows visualization of the cell structure and facilitates 
observation of factors such as differentiation and adhesion. DAPI is a fluorescent 
staining agent which binds to the nucleus of cells, allowing visualization of the nucleus 
including such events as mitosis. Staining with fluorescent compounds was carried out 
according to the following protocol. The day prior to staining, cells were trypsinized 
and counted. Cells were plated in a 6-well plate containing a coverslip at a 
concentration of 4 x 104 cells per 0.5 mL of growth medium. Cells were then incubated 
at 37 ºC at 5% CO2 overnight. Cells were washed with PBS prior to fixing to remove 
BSA, phenol red or any such compounds present in media which could interfere with 
the fluorescent dye. 4% paraformaldehyde (1 mL) was then added to the cells and left to 
incubate at room temperature for 15 minutes. The sample was then washed three times 
using PBS to remove any excess paraformaldehyde. After the final PBS washings were 
removed, fresh PBS (1 mL) was added to each well. To this, 2 μL of rhodamine 
phalloidin (2.5 mg/mL in MeOH) was added and the cells incubated in darkness for 25 
minutes. The sample was again washed with PBS to remove any excess staining agent 
and therefore reduce potential noise levels. The coverslip was removed using tweezers 
and a drop of DAPI staining agent was placed on the surface of the coverslip containing 
cells. The coverslip was then placed on a microscope slide, sample side facing 
downwards and imaged under a fluorescent microscope. 
 
2.3 Flow Cytometry 
 
For the purposes of fluorescence intensity measurements, Flow Cytometry was 
chosen as the most efficient form of data gathering. Flow cytometry measurements were 
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taken using an FCS CANTO II cytometer and analysed using the BD FACS DIVA 
software. 
2.3.1 Flow Cytometry Sample Preparation 
 
The day prior to measurement, cells were cultured on a 24 well plate at 1 x 105 
concentration. Following culture, a 10 μL aliquot of 500 μM inhibitor was added to the 
cells. Alternatively, for inhibitor/LPF complexes, the same concentration of inhibitors 
was diluted in 100 μL Opti-MEM medium followed by the addition of 1 μL LPF. The 
complexes were allowed to form by incubating the sample at room temperature for 20 
minutes and then added dropwise to the wells containing cells. Cells were then allowed 
to grow overnight. Just prior to Flow Cytometry measurement, cells were re-exposed to 
inhibitors or inhibitor/LPF complexes as described previously. Cells were then allowed 
to incubate for 20 minutes at 37 °C. Medium was subsequently removed and cells were 
washed with HBSS buffer. Cells were then trypsonized for 4 minutes at 37 °C in a 
solution consisting of 10X Trypsin in a 1/1 dilution with HBSS. Fresh DMEM media 
was then added to the cells to halt the Trypsin reaction and samples were placed in 
centrifuge tubes. The samples were then spun at 500g for 7 minutes after which media 
was removed and cells were resuspended in HBSS. Cells were then stained with either 
DAPI or DAF-2 DA as described in 2.2.6. For some samples, DAPI staining was also 
used for live/dead screening. To achieve this, 2 μL DAPI dye was added simultaneously 
to DAF-2 DA to 0.5 mL of cells in HBSS at a concentration of 200 μg,  
After a 20 minute incubation period with the fluorescent compounds, cells were 
centrifuged once again and resuspended in HBSS. Samples were then taken for 
measurement using Flow Cytometry. 
 
2.4 Mutagenesis and eNOS chimera 
 
In order to create the eNOS reporter for the biosensor, various relevant DNA 
sequences were obtained and combined so as to create two individual systems capable 
of producing nitric oxide in response to stimuli. The DNA used in engineering 
experiments was obtained from commercially available plasmids. 
 
2.4.1 Plasmids, Sequences and Primers. 
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Primers are short sequences of single stranded DNA. These are used in the 
polymerase chain reaction to select the region of augmented amplification. Many points 
must be addressed when designing primers. Sequence length should be in multiples of 3 
and have a melting point low enough to allow successful PCR. Possible secondary 
structure melting point must also be addressed when planning the annealing cycle of 
PCR. These sequences share a high homology with the target sequence and thereby 
create a point of origin for the sequential addition of bases to the daughter strand of 
DNA. 
 
Plasmids used in this study include: 
 
• pEX_EF1_NOS3-CFP - Purchased from ATCC 
• FKBP-(GGGGS)x2-N-TEV - Generously donated by Chris Voigt Group 
• Frb-C-TEV - Generously donated by Chris Voigt Group 
• pBABE-TetCMV-puro-mVenus-LOV - Purchased from Addgene Inc. 
 
Plasmid pEX_EF1_NOS3-CFP contains the NOS3 (endothelial nitric oxide 
synthase) gene and was used throughout this work relating to the genetic engineering of 
eNOS. Plasmid FKBP-(GGGGS)x2-N-TEV contains the FKBP12 fragment used to 
form the rapamycin CID system used for chemical activation of eNOS. Plasmid Frb-C-
TEV contains the Frb region of the FRAP protein used in conjunction with FKBP12 as 
part of the rapamycin CID system for chemical activation of eNOS. Plasmid pBABE-
TetCMV-puro-mVenus-LOV contains both LOV1 and LOV2 domains, used to create 
the light-sensitive eNOS. 
Plasmid pEX_EF1_NOS3-CFP contains the eNOS gene, the sequence for which is 
given in Sequence 1. The sequence is divided into the oxygenase and reductase domains 
of the protein. The two domains were separated into two different fragments using PCR 
and the primers used are also given in Sequence 1. 
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Sequence 1 Sequence of the eNOS gene and primers used to separate the oxygenase 
and reductase domains. 
 
 
 
Oxygenase: 
5' Primer: CAACAAGTTTGTACAAAAAAGCAGGCTCCG 
3' Primer: GACCTTTAAGGAAGTAGCCAATGCAGTGAA 
 
Reductase: 
5' Primer: AAGGGGGCAGGCATCACCAGGAAG  
3' Primer: GATCAACCACTTTGTACAAGAAAGCTGGGT 
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Forward FUB NEW: TTCAAGGGAAGGGGGCAGGCATCACCA 
Reverse FUB NEW: TGCCCCCTTCCCTTGAAAAGGCTCTCG 
 
 
For the FKBP12 fragment, the FKBP-(GGGGS)x2-N-TEV plasmid was used. The 
Sequence of the fragment and the primers used to extract and amplify it are given in 
Sequence 2 
 
Sequence 2 Sequence of the FKBP12 fragment and primers used in amplification. Blue: 
FKBP12. Green: Gly/Ser linker. 
 
 
 
5' Primer: GCCACCATGGGTGTGCAGGTAGAAACAATC 
3' Primer: CCACCACCGTCGCCCCCTCCACCAAGGCCG  
 
The Frb-CTEV plasmid was used to obtain the second protein involved in the 
Rapamycin CID system. The Frb fragment and the primers used in PCR are given in 
Sequence 3. 
 
Sequence 3 Sequence of the Frb fragment and primers used in amplification. Blue: 
FKBP12. Green: Gly/Ser linker. 
 
 
 
 
5' Primer: GCCCACCATGGAGATGTGGCACGA 
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3' Primer: GGTATCAGAGACCATGCTGCTCATGGA 
 
To produce the fragment necessary for fusion into the novel chimeric eNOS, 
fragments must be prepared for Gibson ligation protocol. The fragments must undergo 
PCR with primers that elongate the sequence so as to create a region of homology 
approximately 20 base pairs in length. This is necessary as the T5 exonuclease activity 
will then digest the sequences and a region of complementary homogeneity is necessary 
for the T4 ligase to re-ligate digested sequences. Primary (eNOS) fragments were 
obtained from plasmid pEX_EF1_NOS3-CFP. Secondary fragments (FKBP12 and Frb) 
were obtained from plasmids FKBP-(GGGGS)x2-N-TEV and Frb-C-TEV. The primers 
used in PCR are given in Sequence 4 along with the expected sequence for 
oxygenase/Frb and reductase/FKBP12 domains. Green represents the eNOS sequence 
and red the Frb sequence. Theoretically, in the presence of rapamycin the protein 
resulting from the chimeric sequences described in Sequence 4 would be brought within 
sufficient proximity to each other to allow the oxygenase/reductase domains to interact 
and therefore restore function to the inactive protein. Primers used in oxygenase/Frb and 
reductase/FKBP12 fusion and expected resulting sequences: 
 
Sequence 4 Sequence of the oxygenase/Frb fragment and primers used. Blue: FKBP12, 
Green: Gly/Ser linker Orange: eNOS gene. 
 
For Oxygenase/Frb fusion: 
5' Primer:  TAGCCAATGCAGTGAAGCCCAATGCCATGGAGA 
3' Primer: TCGTGCCACATCTCCATGGCATTGGGCTTCACT 
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Sequence 5 Sequence of the reductase/FKBP12 fragment and primers used. Blue: 
FKBP12, Green: Gly/Ser linker Orange: eNOS gene. 
 
 
For Reductase/FKBP12 fusion: 
5' Primer: TTCAAGGGAAGGGGGCAGGCATCACCA 
3' Primer: TGCCCCCTTCCCTTGAAAAGGCTCTCG 
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To produce the light sensitive mutant strain of eNOS, the eNOS protein was 
separated at three different points close to FMN binding domains. The region of the 
eNOS gene that binds eNOS is given in Sequence 6. 
 
Sequence 6 The FMN binding region of eNOS. 
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Three segments were obtained using the 5' primer of the oxygenase domain of eNOS 
and the 3' primers a, b and c, resulting in sequences 7 a, b and c, respectively. 
 
Sequence 7 Primers used to construct sequences a, b and c. 
 
a. 3' - ATACAGAATGGTTGCCTTCACACGCTT 
b. 3' - GCCAAGAGGATACCAGTGGGTCTGAGC 
c. 3' - CAGCTTTGGCATCTTCTCCCACACAGA 
 
 
 
 
 
 
 
 
 
 
 
 
 
a: 
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b: 
 
 c: 
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To construct the complementary fusion fragment, the plasmid pBABE-TetCMV-
puro-mVenus-LOV was used to obtain the DNA for the LOV domain, the sequence for 
which is given in Sequence 8. The aim was to then fuse the created segments which 
terminate in different areas of the FMN binding domain of eNOS to LOV1/2 domains to 
create the light sensitive mutant. 
 
Sequence 8 Sequence of the LOV domain. 
 
 
 
 
 
2.4.2 Electroporation  
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Electroporation is an effective method of transforming competent cells using 
appropriate plasmids in bacteria. It uses sonication to induce an increase in membrane 
porosity which increases transformation efficiency. The technique requires placing all 
the reagents on ice to achieve isothermal conditions. Cells are made competent by 
growing a colony to OD600 0.6 (+/- 0.2) and then stopping growth by placing the cells 
on ice for 1-2 minutes. Cells are then spun at 5000 rpm for 3 minutes and supernatant is 
removed. The cells are then resuspended in 10% glycerol and the spin/resuspend cycle 
is repeated twice. The sample is centrifuged one last time and the pellet is transferred to 
a falcon tube at 4 °C. The cells are then aliquoted for immediate use or placed in a 
freezer at -80 °C for storage. To transform these competent cells, electroporation was 
used. The competent cells are placed on ice together with the other reagents. After 
isothermal conditions have been achieved, 70 μL of cells are added to a cuvette along 
with 2-10 μL DNA (i.e. plasmid DNA). The lower the amount of DNA the safer the 
outcome as if there is too much salt in the solution (originating from the DNA buffer) 
the cells will die during electroporation, an event termed “sparking”. The cuvette is 
placed in the electroporator and the device turned on. The time constant value should be 
higher than 3.5 as a value lower than 2 signifies a sparking event. After electroporation 
is complete, SOB medium (1 mL) is added to the cuvette and the cells are incubated for 
1 hour at optimum temperature (which varies according to the cells/genes used) for 
recovery. The incubation step is only necessary when the cells are to be grown in/on 
antibiotic medium, as it takes the cells time from plasmid takeup to express the 
necessary proteins to confer antibiotic resistance. After the incubation step, cells are 
plated on appropriate medium. The protocol described is applicable to bacteria such as 
E.coli.  
 
2.4.3 Miniprep 
 
The purpose of this technique is to extract plasmid DNA from bacteria. As the 
plasmid is a small piece of circular DNA, when the cells are lyzed in steps, the plasmid 
DNA remains in supernatant. This is cleaned and extracted and the resulting plasmid 
DNA can be cut by restriction enzymes and run on a gel to check whether the correct 
DNA was extracted using the miniprep.  
The technique was performed using the Qiagen Miniprep Kit. Cells were spun down 
from a culture at 4000 rpm and the supernatant was removed. The resulting pellet was 
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resuspended in P1 buffer (250 μL). This was mixed by pippetting and transferred to a 
1.5 mL eppendorf tube, followed by the addition of P2 buffer (250 μL). The solution 
was gently mixed by inversion until no clumps remain visible. Up to a maximum time 
of 5 minutes is allowed for lysis to occur, otherwise DNA damage is possible. N3 buffer 
(350 μL) was then added to the solution and this was mixed by gentle inversion, 
whereupon large amounts of precipitate are generated. 
The resulting mixture was centrifuged at 13,200 rpm for 10 minutes and the 
supernatant was gently captured and placed in a flow column. The column was 
centrifuged at 13,200 rpm for 30 seconds and the flow-through was discarded. This was 
followed by the addition of PB (500 μL) and a repeat of the previous spin cycle. After 
discarding flow-through, PE buffer (750 μL) was added, followed by a repeat of the 
13,200 rpm 30 second spin cycle. Flow-through was discarded and the sample was then 
allowed to run dry at 13,200 rpm for 2 minutes. The column was transferred to a 1.5 mL 
eppendorf tube and dH2O (50 µL) was added and the column spun at 13,200 rpm for 30 
seconds. The flow-through was reloaded and the previous step repeated to ensure 
maximum DNA capture. DNA concentration was then verified using NanoDrop 
spectrophotometry. 
 
2.4.4 Restriction Digest 
 
Restriction Digests are an important technique in molecular biology. These utilize 
enzymes that recognize specific sites in DNA and cleave the sequence in a specific 
manner, generating sticky or blunt ends. This allows the construction of recombinant 
proteins by matching cutting sites in different sequences so that the sticky overhangs 
match. 
For a 50 μL reaction volume, 1 μL of each restriction enzyme is added, as well as 2 
μg DNA and 5 μL of appropriate 10 x buffer. The type of buffer used depends on the 
enzyme, for example AccI requires buffer 4. Ultrapure water is used to raise the volume 
to 50 μL and the sample is placed in a heating block or water bath at the desired 
temperature (enzyme specific) for 2-3 hours. The sample is then brought to inactivation 
temperature (whereby the enzymes are permanently denatured, halting the restriction 
digest), which varies depending on the proteins used. Some enzymes are not heat 
inactivated (meaning the temperature required to inactivate the enzyme is high enough 
to destabilize the DNA). In these cases the sample is run on an agarose gel and 
subsequently gel extracted to separate the proteins from DNA in solution. The sample 
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can then be stored at -4 °C until it is needed. It is always recommended to run the results 
of a restriction digest on a gel to confirm that the obtained fragment number and sizes 
match those expected.(Stocks, Thorn, & Galton, 1992) It is advisable to use the digested 
DNA as soon as possible for ligations as the DNA is made substantially more 
susceptible to damage after digestion. 
 
2.4.5 PCR 
 
PCR is a technique which amplifies desired sections of DNA. It requires the use of 
forward and reverse primers (small sequences of DNA which are homologous to 
flanking regions of the DNA of interest) that will selectively amplify DNA. The 
procedure requires placing all reagents on ice to achieve isothermal conditions. In a 100 
μL tube, buffer HF (5 µL) is added, along with each primer (1 μL) and DNA (1-2 μL). 
To this 10 mM DNTP (1 μL) is added in a 7.5 mM magnesium chloride buffer. 
Subsequently, Taq polymerase protein (0.5 μL) is then added followed by water to bring 
the reaction volume to 50 μL. The solution then undergoes a series of thermal cycles 
leading to denaturation, annealing and extension. Temperature values vary with the type 
of PCR and the primer sequence. Primers with high GC content tend to have higher 
melting temperatures, requiring adjustment. PCR with an extended initial 95 °C period 
can be used to break up cells. A small mixture of cells is added instead of the sample 
DNA and cells are lyzed by using high temperature and thus release DNA. Primers can 
then amplify specific regions. This technique is termed "Colony PCR" and is useful as a 
quick method to confirm the existence of DNA of interest in the bacterial sample. 
For PCR containing primers of different melting temperatures, touchdown PCR is 
applied. This procedure involves cycling of temperatures for primer melting. For 
example, with primers of melting temperatures 60 and 65 °C, touchdown PCR will 
entail thirty seconds at 66 °C, thirty seconds at 64 °C, thirty seconds at 62 °C and thirty 
seconds at 60 °C. This ensures that both primers have melted and annealed to their 
respective sequences. 
 
2.4.6 Gels 
 
Agarose gels were prepared to differentiate fragments of DNA according to size. A 
plasmid or section of DNA is selected and then cut with restriction enzymes. If the 
observed fragment sizes match predicted ones then the correct reactions have occurred. 
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The agarose concentration of the gel depends on the size of expected fragments of 
interest. For fragments smaller than 1 Kb a concentration of 2% agarose is used. For 
fragments between 1 Kb and 5 Kb a varying concentration range of between 1 and 2% 
is available. Fragments larger than 5 Kb require a gel containing a lower percentage of 
agarose gel (0.8%). If the concentration is too low, then the gel may melt during 
electrophoresis.  
Gels were prepared in 1 x TAE buffer containing the desired concentration of 
agarose. This was then microwaved until there were no visible particles and the gel was 
poured into the mold. After evaporation had ceased, ethidium bromide was added to the 
setting gel. This hybridizes with DNA and fluoresces under UV light, allowing 
visualization of DNA fragments which are then compared with a DNA ladder to 
determine fragment size. Combs are then placed in the gel and it is allowed to cool. The 
teeth of the comb form the wells into which DNA is introduced. Alternatively, Safeview 
was used as a replacement for ethidium bromide due to its increased safety. However, 
Safeview is heat inactivated therefore it must be added when the gel is cooled to below 
65 °C. Once the gel had hardened it was placed in an electrophoresis tank containing 
TAE buffer. Electricity is subsequently run through the tank (70-130 mV) which causes 
DNA to translocate based on size/charge separation.(Helling, Goodman, & Boyer, 
1974) Once the gel has run through, the desired DNA band can be excised from the gel 
using a scalpel and the DNA can be removed from the agarose using gel extraction. 
 
2.4.7 Gel Extraction 
 
This procedure consists of initial physical removal of DNA from the gel using a 
scalpel. A UV lamp should be used to visualize DNA aggregation locations and the cut 
should be made so as to include the minimum amount of agarose gel possible. The gel is 
then liquefied by the addition of 1.5 μL of diffusion buffer per 1 mg of gel and exposure 
of the sample for 30 minutes to a temperature of 50 °C. The sample is then spun at 
13,200 rpm for 1 minute and transferred to a filter column. The mixture volume is then 
determined and 3:1 volume of QG buffer is then added upon which the mixture should 
turn yellow in colour. The column is placed in an appropriate collector and further spun 
at 13,200 rpm for 30 seconds. The collector is changed and EB buffer (50 μL) is added 
to the column, followed by a further 30 second spin at 13,200 rpm. Flow-through is 
added to the column and left to stand for 1 minute, after which the sample is spun again 
for 30 seconds and DNA is obtained from the collector. 
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2.4.8 Conventional Ligation 
 
The aim of ligations is to fuse two sources of DNA which have been digested with the 
same restriction enzymes. These are commonly carried out using a double digest to 
allow for control of the orientation of the fragments being ligated. The standard protocol 
for ligations is: 
 
1 μL DNA (concentration >250 ng/μL) 
1 μL T4 ligase 
1 μL Ligase Buffer 
7 μL dH2O 
 
There are several temperatures at which ligation is permissible, with varied protocols. 
The approach taken was 22 °C for four hours followed by 4 °C for two hours. DNA 
which has been ligated to a vector such as a plasmid can subsequently be used directly 
for host transformation. 
Ligations performed for the pTARGETTM system use settings similar to the ones 
above described, however a different source of T4 ligase and ligase buffer are used as 
some T4 ligases contain exonuclease activity. In addition, pTARGETTM ligations 
involved placing the ligation sample at 4°C for twelve to eighteen hours as opposed to 
the protocol for standard ligations described above. 
 
2.4.9 Gibson Ligation 
 
The aim of the Gibson Ligation is to fuse two different sequences of DNA together. 
To achieve this, both DNA fragments must be pre-modified to contain overlapping ends 
complimentary to each other. To prepare the sequences for Gibson Ligation of 
fragments A and B, primers must be designed so as to create an overlap between the 
two sequences. The primers should be designed so that PCR of fragment A will result in 
an end product containing at the 3' end the first 20 bases of fragment B. The PCR of 
fragment B should result in a sequence containing the last 20 bases of fragment A at the 
5' end of the sequence. The PCR of the two fragments thus creates a 40 bp region of 
overlap between the two genes.(Gibson et al., 2009) 
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Gibson Ligation one step isothermal reaction master mix (giving a final volume of 6 
mL): 
 
3 mL 1 M Tris-HCL pH 7.5 
150 μL 2 M MgCl2 
60 μL 100 mM dGTP 
60 μL 100 mM dCTP 
60 μL 100 mM dATP 
60 μL 100 mM dTTP 
300 μL 1 M DTT 
1.5 g PEG 8000 
300 μL 100 mM NAD 
 
Final reaction mix with final volume of 1.2 mL: 
 
320 μL of master mix 
0.64 μL T5 exonuclease 
20 μL 2U phusion polymerase 
160 μL 40U Taq DNA ligase 
699.46 μL of dH2O 
 
For the reaction carried out, the DNA to be assembled (5 μL) was added in 
equimolar amounts to 15 μL of the final reaction mix and incubated for sixty minutes at 
50 °C. This reaction results in the formation of a novel sequence combining the 
fragments in question to create a chimeric gene, which when expressed in the 
appropriate vector will create the designed protein. 
 
2.5 Measurement System Setup 
 
Once mutant strains of CHO-K1 were achieved, an electrode setup was prepared to 
measure NO output from chimeric eNOS. Amperometric measurements were performed 
using a modified Pt working electrode and an Ag/AgCl combined reference and counter 
electrode.  
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Figure 17 Electrode setup used for measurements. A) Potentiostat, B) micro-cloth 
polishing pad, C) gator clips, D) electrodes immersed in solution, E) magnetic 
stirrer. 
 
 
Figure 18 The electrodes used for measurement. A) Modified platinum working 
electrode and B) the Ag/AgCl reference/counter electrode. 
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2.5.1 Electrode Preparation 
 
A Pt Electrode was cleaned with aluminium silicate 2 μm bead slurry and a 
microcloth polishing pad. The electrode was connected to a potentiostat from Iviumstat 
and then immersed in a 0.1 M NaOH, pH 13 solution containing 2 mM NiTSP. Fifteen 
cycles of cyclic voltammetry were then applied to the electrode using settings of 0-1.2 
V(+) and a scan rate 100 mV/s. This step is necessary to achieve NiTSPc 
electrodeposition on the electrode surface. The electrode was then removed from 
solution and allowed to dry at ambient temperature (approximately 10 minutes). The 
surface of the electrode is further modified by the addition of 5 μL Nafion 117 solution 
followed by adequate drying time (10-15 minutes). These procedures modify the 
electrode surface allowing interaction with NO, whilst excluding other agents. In the 
absence of the Nafion layer, the electrode would be more susceptible to interaction with 
compounds similar to NO.  
 
2.5.2 Electrode Measurements 
 
Mammalian Cells were grown overnight in 24 well plates with appropriate medium 
and eNOS. Medium was then aspirated and the cells were washed in PBS. Following 
this step, cells underwent Trypsin treatment before being resuspended in PBS and 
washed twice. Final cellular resuspension was done in PBS at 37 °C. This step was 
necessary to remove free-floating proteins and cellular detritus, which could potentially 
interfere with the experiment. Other components in DMEM medium such as phenol red 
and FBS may also interfere with measurements. A pre-prepared electrode is then 
immersed in the well so as to be in contact with the cell-suspension solution. Cells were 
in suspension to maximize exposure of the electrode to NO. The electrode was then 
placed at a constant potential of +750 mV and a background current reading of NO was 
taken for a period of ten minutes. Stimulus in the form of white light was then 
introduced using a Dinotte Lighting high intensity lamp and a continuous reading of the 
release of NO in the form of current was taken.  
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Chapter 3 The activity of eNOS in CHO-K1 cells 
 
In chapter 1 a detailed discussion of nitric oxide synthase proteins was presented and 
a strategy towards creation of a chimeric eNOS protein described.  It was hoped that the 
eNOS analogue can be incorporated into mammalian cells, with the CHO-K1 line 
selected as a prime candidate due to its robust nature and enhanced ability to expressed 
proteins. However, prior to transfection a detailed characterisation of the wild type cells 
was required.  
 
 
3.1 Assessing Cellular NO production using diaminofluoresceins 
 
In order to quantitatively assess NO production in the chosen cell line, a series of 
experiments were designed in which cells were fluorescently labelled and their 
fluorescence intensity measured as a marker for NO production. Fluorescent stains 
provide a vital tool to visualise specific areas within cells, for example, phalloidin-based 
compounds bind to the actin cytoskeleton, whilst DAPI selectively stains cell nuclei and 
also acts as a live/dead assay. Such fluorescent compounds can also be used to 
selectively stain small molecules, such as nitric oxide, produced within cells. 4,5-
diaminofluorescein diacetate (1) is a cell permeable dye.(Hirotatsu Kojima et al., 
1998), (Hirotatsu Kojima, Naoki Nakatsubo, et al., 1998) Once inside the cell the acetate 
groups undergo hydrolysis by intracellular esterase activity to generate the more 
reactive DAF2 parent compound (2). Rapid reaction with NO produced within the cell 
yields the highly fluorescent triazolofluorescein (DAF-2T) (3) which can be visualised 
under a fluorescence microscope equipped with a fluorescein filter set or the 
fluorescence intensity quantised via flow cytometry using an excitation filter of 492 nm 
and an emission filter of 515 nm. 
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Figure 19 Reaction between DAF-2 DA and Nitric Oxide in vitro (taken from 
www.sigmaaldrich.com). 
 
3.1.1 Inhibition of NOS 
 
The study of NO expression in CHO cells also provides a novel opportunity to 
examine eNOS inhibition in vitro. NO has been implicated in a wide variety of 
processes in vivo giving the molecule, and in particular its inhibition enormous 
pharmacological significance.  A wide variety of compounds have been shown to inhibit 
NOS activity, ranging from mimics of L-arginine to substituted citrulline deriviatives 
such as thio- and alkylthiocitrullines and hererocyclics such as nitroindazole or 
imidazole derivatives.(P K Moore & R. L. Handy, 1997)  The first reported case of 
NOS inhibition used a methylated analogue of L-arginine, known as L-NMMA (Figure 
20).(Olken & M. a Marletta, 1993) Inhibition of NOS by arginine mimics (of which L-
NNA is also an example)(Furfine, Harmon, Paith, & Garvey, 1993) is thought to occur 
to via a competitive binding mechanism however the precise nature varies according to 
both the substrate and NOS isoform. The process is highly stereospecific with D 
analogues demonstrating little or no inhibitory effect. Generally amino acid based 
inhibitors show little selectivity between NOS isoforms in vitro).(P K Moore & R. L. 
Handy, 1997) 
 In contrast, hererocyclics such as the nitroindozole 7-NI are believed to bind to the 
haem domain of NOS and consequently disrupt electron transfer through the protein, 
preventing NO formation.(Babbedge, Bland-Ward, S. L. Hart, & P K Moore, 1993) 
Interestingly, interaction between 7-NI and haem also interferes with the binding of L-
arginine and BH4, which may explain the apparent inhibitory nature of this compound 
at alternative sites.(R. L. C. Handy et al., 1996),(Klatt et al., 1994) 
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Figure 20 Structures L-arginine and of the NOS inhibitors L-NNA, LNMMA and 
7-NI. 
 
For the purpose of this study three commonly used NOS inhibitors, L-NNA, L-
NMMA and 7NI were selected and introduced to the cell culture in order to evaluate 
their activity on cellular NO production. A working concentration of 50 μM was used 
for each inhibitor. This value was derived so as to be several times higher than the IC50 
value of the inhibitors' action on eNOS. The IC values for the purified protein were 
obtained from the work of Alderton et al and are quoted as 0.35 μM, 3.5 μM and 11.8 
μM for L-NNA, L-NMMA and 7-NI, respectively.(Alderton et al., 2001) By using a 
concentration several times higher than the IC50 value it is expected that that the 
inhibitory effect would be sufficient to be observed via flow cytometry methods. 
However, these concentrations are deliberately somewhat lower than those used in 
previous studies in order to evaluate whether such concentrations were sufficient to 
inhibit eNOS production in CHO cells.(Zhan, D. Li, & Johns, 2003), (Navarro-antolin & 
Santiago Lamas, 2001) 
 
3.1.2 Lipofectamine-based delivery 
 
Despite the extensive study of NO inhibitors over the past two decades, the cell 
permeability of these compounds has not been thoroughly investigated. In order to 
probe the uptake of inhibitors into CHO cells, a liposomal delivery method was devised 
comprising pre-incubation of the inhibitors with Lipofectamine LTX. These 
 69 
commercially available liposomes are routinely used in the Lipofection route of 
Eukaryotic cell transfection,(Herrera, Hong, & Garvin, 2006) as shown in Figure 21. 
Although the exact nature of Lipofectamine has not been disclosed, the system is known 
to be cationic and provides an efficient means to deliver DNA into cells.  It was 
therefore thought that use of these liposomes which are known to be compatible with 
mammalian cell membranes would increase intracellular inhibitor concentration 
providing an interesting comparison with natural uptake of NO inhibitors. 
 
 
 
Figure 21 Transfection of DNA into cells using Lipofectamine (taken from 
invitrogen.com). 
 
3.2 Inhibition of NO production in CHO-K1 cells – effect of inhibitor type 
and lipofectamine delivery 
 
In order to probe the production of NO within CHO-K1 cells, a series of 
experiments were designed using DAF-2 DA as a selective stain for nitric oxide. In the 
first instance the production of NO was assessed in native cells and compared to those 
treated with known inhibitors of NO. In an analogous experiment, cells were treated 
with identical concentration of inhibitors in the presence of lipofectamine in an attempt 
to increase the proportion of inhibitor incorporated into the cell. An initial qualitative 
analysis of NO production was carried out using a fluorescence microscope prior to 
quantitative measurement of fluorescence levels using flow cytometry. 
 
3.2.1 Fluorescence microscopy 
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Prior to flow cytometry analysis, cells were imaged using fluorescent microscopy to 
verify the activity of the used Fluorescein and whether any qualitative/quantitative 
information could be gathered from this type of data. 
 
Figure 22 DAF-2 DA staining of CHO-K1 cells. Images A and B are of control 
samples, untransfected cells, at 10x and 20x magnification respectively. Images C 
and D are of cells transfected with the PEX_EF1-CFP_NOS3 plasmid at 10x and 
20x respectively. Images on each column were taken with the same exposure time 
at the same magnification. Image modification was also regulated for all images to 
undergo the same change in histogram. Exposure time for each column was set 
using the PEX_EF1-CFP_NOS3 mutant cell line and the control image was 
subsequently taken using the exposure time automatically calculated for the 
mutant cell line. 
 
A B 
C D 
10X 20X 
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Figure 23 Fluorescent imaging using DAF-2 DA of control and the PEX_EF1-
CFP_NOS3 mutant line. A) Control cell line. B) the PEX_EF1-CFP_NOS3 mutant 
cell line. These images were taken using the same method as the images in the 
previous figure, with the exception that the exposure time calculation was done 
inversely. Exposure time was set using the control cell line and subsequently the 
PEX_EF1-CFP_NOS3 mutant cell line was imaged using the exposure time 
calculated for the control image.  Both images were taken at 20x magnification. All 
image processing was constant for both images. 
 
As can be seen in Figures 22 and 23 transfected cells showed a higher fluorescence 
intensity than untransfected cells. This suggests that the mutant cell line is in fact 
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producing NO at abnormally high quantities. At a higher magnification, as illustrated in 
Figure 24, it can be seen that NO production is localized within the cell. 
 
 
 
Figure 24 A 40x Magnification of the CHO-K1 mutant cell line transfected with 
the PEX_EF1-CFP_NOS3 plasmid. NO detection shows higher concentrations 
around the nucleus, whilst some cells appear to contain substantially higher levels 
of NO.  
 
A proportion of the cells exhibit significantly higher fluorescence intensity than the 
majority of the sample, which can be attributed to higher intracellular NO 
concentrations. There are a number of possible explanations for the observed 
fluorescence. These include variation of expression rates of the eNOS gene within the 
cell, the availability of co-factors in solution (competitive binding) and the position of 
the cells within the growth cycle, with initiation of the apoptotic cycle leading to 
production of NO via non-NOS pathways. 
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3.2.2 Flow Cytometry Analysis 
 
Flow cytometry is a powerful technique used in the analysis of micron-sized 
particles and cells. A beam of monochromatic light (usually from a laser) is directed on 
to the sample stream, whilst detectors placed in line with (forward scatter) and 
perpendicular to (side scatter) analyse the scattered light. If the particle or cell is 
fluorescently labelled, emission may occur at a different wavelength from the incident 
light source. A combination of scattered and fluorescent light is identified by the 
detectors and by analysing fluctuations in the brightness of each emission peak it is 
possible to derive a myriad of useful information about each individual particle or cell. 
For example, forward scatter correlates well with cell volume, whilst side scatter can 
give an insight into internal components of a particle, such as the shape of cell nuclei. 
In many flow cytometry experiments a combination of fluorescent dyes are 
employed which each have characteristic emission wavelengths. For this reason there 
are numerous methods of data analysis and interpretation, depending upon the 
information sought from the experiment. Therefore, prior to delving into experimental 
results an overview of the analytical method must be given. As each type of experiment 
conducted using flow cytometry uses different parameters and each type of sample can 
behave differently, these must be standardized as much as possible throughout 
experiments whilst preserving the integrity of the data being collected. 
In the first instance a plot of side scatter (SSC-A) vs forward scatter (FSC-A) allows 
the sample gate to be selected. The chosen "sample" gate must encompass the entirety 
of the cell population being observed whilst filtering out other compounds such as 
cellular debris (shown in black). As living cells from a cell line will exhibit similar 
morphology it is reasonable to assign the large population (shown in purple and blue) to 
a living cell population. 
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Figure 25 A flow cytometry sample exhibiting the "sample" gate chosen. The 
population of interest can easily be distinguished using Side Scatter2 vs Forward 
Scatter2. As living cells from a cell line will exhibit a similar morphology to each 
other it is safe to assume that the large population (shown in purple and blue) 
contains a living cell population. 
 
Once the sample gate has been established a more detailed analysis of the data is 
required. Cells which are positive for DAF-2DA indicate the production of NO, 
however as NO is an active player in cellular apoptosis, it was also necessary to assess 
whether apoptotic cells are contributing to the NO measurements obtained. To achieve 
this, cells were co-stained with DAPI as an indicator of cell death. DAPI demonstrates 
greater permeability to dead cells than their live counterparts resulting in higher 
fluorescence intensity. This allows removal of DAPI positive cells from the overall cell 
population as well as a providing a method of verifying whether apoptotic cells 
contribute to the measured NO. A plot of DAPI fluorescence intensity vs forward 
scatter shows two populations, which are attributed to live (blue/purple) and dead (red) 
cells, respectively.  
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Figure 26 A flow cytometry sample demonstrating the "Dead" population gate. All 
cells portrayed in this figure are within the "Sample" gate mentioned in Figure 24. 
Dead cells have a higher fluorescence in the 405 450/50-A measurement due to 
DAPI staining. DAPI is excited using an Ultraviolet laser with an excitation of 
405nm and emission of 450nm. As can be observed, DAPI positive cells occupy a 
different area to the cell population of interest in respect to their 405 450/50-A 
fluorescence and can therefore easily be excluded. 
 
Once the dead cells are excluded from the analysis, the remaining live population 
can be considered which is achieved via inversion of the "dead" gate. A plot of DAF-2 
DA emission fluorescence intensity vs forward scatter illustrates two distinct 
populations which are termed “negative” and “positive”. The positive population 
displays significantly higher fluorescence, suggesting that cells within this population 
are actively producing NO, whilst those in the negative population display production of 
NO at a substantially lower level. It can be noted that in Figures 26 and 27 the axes are 
inverted; the axes on which each parameter is displayed is arbitrary in both cases and 
are assigned to give the best definition between the two populations in order for them to 
be separated. Once the populations of interest have been assigned, a histogram of cell 
count vs fluorescence intensity can be constructed, clearly indicating the proportion of 
cells in the “negative” and “positive” populations Figure 28.  
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Figure 27 A flow cytometry sample showing the "Live" population of cells under 
488 530/30-A fluorescence, the emission spectrum of DAF-2 DA. It was noted that 
two distinct populations were observed. These were termed "Negative" (Blue) and 
"Positive" (Pink) as one has a distinctively lower fluorescence than the other. It 
was therefore assumed that one population is actively producing NO whilst the 
other has a substantially lower level of NO production. 
 
 
 
Figure 28 A flow cytometry histogram produced from data which has been 
processed as delineated in Figures 25-27. The histogram depicts cell count vs 
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fluorescence intensity on a 488 530/30-A (DAF-2 DA) emission spectrum. The two 
populations, "Negative" (Blue) and "Positive" (Pink) can be observed. 
 
In order to probe whether apoptotic cells contribute to the positive or negative 
populations, the DAF-2 DA fluorescence of DAPI positive cells was investigated. 
Figure 29 shows that DAPI positive cells only contribute to the fluorescence of the 
negative population and therefore are not actively producing NO. This would indicate 
that for the purposes of this experiment, dead/dying cells do not contribute to shifts in 
the positive population. 
 
 
Figure 29 Population histogram from 488 530/30-A (DAF-2 DA fluorescence) data. 
Blue) Negative Population, Pink) Positive Population, Red) DAPI positive 
population. 
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Figure 30 Flow cytometry histogram results. This figure depicts the data gathered 
from the flow cytometry experiment. Only one representational histogram for each 
sample shown. A) Control B) With inhibitor L-NMMA C) With inhibitor L-NNA 
D) With inhibitor 7NI E) With inhibitor mix F) With LPF/L-NMMA G) With 
LPF/L-NNA H) With LPF/7NI I) With LPF/inhibitor mix. 
A B 
D C 
E F 
G H 
L-NMMA 
L-NNA 
CTRL 
7NI 
LPF/7NI 
LPF/L-NMMA 
LPF Mix 
LPF/L-NNA 
I 
Mix 
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The analysis discussed in section 3.2.2 was applied to each sample in turn and 
examples of the fluorescence histograms obtained are shown in Figure 30. Addition of 
inhibitors in the absence of lipofectamine appears to have little impact upon cellular NO 
production. This suggests that the concentrations used (50 µM) are insufficient to cause 
effective inhibition, in contrast to those reported to inhibit NO production in a purified 
protein. However, in the presence of the liposomes/inhibitor complexes, production of 
NO is attenuated to a significant extent.  
In order to quantify changes in the populations relative to the control sample a 
statistical analysis of the data was performed. The results are illustrated in Figures 31 
and 32 and correlate well with initial observations based upon visual inspection of the 
histograms. Introduction of the lipofectamine reagent in the absence of inhibitors had no 
effect on NO production, Figure 31. Within the error limits of the experiment none of 
the inhibitors tested showed significant changes in the positive and negative 
populations, appearing very similar to the control, Figure 32. In contrast, many of the 
inhibitor/lipofectamine complexes did lead to substantial changes, which are also 
illustrated as percentage changes relative to the control in Figure 32. 
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Figure 31 The effect of lipofectamine on the cellular production of NO. It can be 
observed from the figure that there is no significant difference in the positive and 
negative populations of the two samples (N=6). 
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Figure 32 Statistical representation of the positive and negative populations in each 
group of samples. For each sample approximately 10,000 datapoints were gathered 
and for all samples N=6.  Samples marked ** show  p<0.01 relative to the control 
and * p<0.05, relative to sample indicated. 
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Figure 33 A representation of the change in populations of samples with inhibitors 
and LPF/inhibitor complexes. All population data was compared to the Control 
sample shown in Figure 31 to generate a change in percentage from the control. 
(N=6) 
 
It is interesting to note that LPF-inhibitor complexes containing mimics or L-
arginine, in particular the nitro analogue L-NNA, are significantly more effective in 
attenuating NO production than those containing the heterocyclic 7-NI. This is likely 
due to the inhibition mechanism which differs between the two inhibitor systems as 
discussed in section 3.1.1.  
 These experiments also confirmed that cell permeability presents a major barrier 
to incorporation of the inhibitors and that liposomal delivery of these compounds 
proved an effective method of overcoming this barrier. Therefore, although LPF-
inhibitor complexes provide a poor comparison for uptake of inhibitors in vivo, effective 
transport of the inhibitor into the cells permits differences in intracellular activity to be 
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observed which are not apparent using the inhibitors alone. Again this finding is 
interesting as L-arginine is expected to be readily available in the intercellular 
environment whereas related mimics appear to be less readily incorporated. It is also 
noteworthy that in the presence of lipofectamine low concentrations of inhibitor are 
sufficient to be effective.  
 
3.3 Inhibition of NO production in mutant vs wild type CHO-K1 cells 
 
In order to investigate how the insertion of the eNOS gene into the wild type cell 
population affects NO production, an experiment was designed using the LPF/inhibitor 
complexes discussed in sections 3.1-3.2. Cells were transfected using the PEX_NOS3-
CFP plasmid and both the wild type and mutant population were subjected to 
LPF/inhibitor complexes. LPF/inhibitor complexes were chosen due their enhanced 
inhibitory effect in comparison with the inhibitors in isolation. An assessment of the 
live/dead cells via DAPI staining was not included as results in section 3.2.2 confirmed 
that DAPI positive cells only effect the negative population. 
 
3.3.1 Flow Cytometry Analysis 
 
Mutant and wild type cells were treated with inhibitor/lipofectamine complexes as 
described in section 3.2. The flow cytometry data was then analysed as described 
previously, and the resultant histograms are given in Figure 34. Positive populations are 
shown in green and negative in blue. A statistical analysis of the data is given in Figure 
35, whilst changes in the percentage populations relative to the control are given in 
Figure 36. 
It is interesting to note that that within the error limits of the experiment, baseline 
NO production is similar in both cell lines. This is not entirely unexpected and one 
possible explanation may be that in the mutant cell line, native cell machinery 
responsible for NO production is suppressed in favour of NO production via the 
incorporated eNOS gene. This is most likely due to the type of promoter being used for 
eNOS expression, EF1. As cells cannot actively repress EF1 for fear of losing cell line 
integrity, cells may be suppressing other sources of NO to prevent NO levels from 
reaching cytotoxic proportions. These other sources of NO are likely to be wild type 
NOS present in the cell line.  
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Figure 34 A) wild type Control B) wild type L-NMMA C) wild type L-NNA D) wild 
type 7N E) wild type inhibitor mix F) Mutant Control G) Mutant L-NMMA H) 
Mutant L-NNA I) Mutant 7N J) Mutant inhibitor mix. Green) Negative 
Population, Blue) Positive Population. 
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Figure 35 The percentage of positive and negative populations in all samples. For 
all samples N=6. Samples marked with ** have a p value of p<0.01. 
 
It is also observed that inhibition is much more prevalent in the mutant than the wild 
type cell line (Figure 36) when the two are compared under identical experimental 
conditions. This is probably due to an alteration in the cell's NO production methods, 
which in turn would be a response to the inserted protein's activity. Although initial 
observations suggest that inhibitors that mimic L-arginine are slightly more effective in 
transfected cells than the heterocyclic 7-NI, there is no statistical difference between the 
four lipofectamine/inhibitor complexes employed. We suggest that in mutant cells the 
inhibitors initially suppress NO production via the e-NOS pathway. This may be 
compensated for via reactivation of the native cellular machinery however this is then 
also inhibited. As NO production is attenuated from two sources the reduction in the 
population of positive cells is much greater for mutant vs wild type cells, which only 
have a single means to produce NO. 
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A final observation is a slight reduction in cell volume in the positive versus 
negative populations for both mutant and wild type cells, as evidenced by histogram 
plots of forward scatter. However, upon further investigation the differences between 
the two populations were not shown to be statistically significant.  
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Figure 36 The Percentage change in populations vs the controls for each sample 
undergoing inhibition. It is quite clear that the changes in positive/negative ratio 
are significantly higher for the mutant cell line when compared to the wild type 
cell line. 
 
3.4 Discussion 
 
The use of liposomes as agents for drug delivery is widely reported.(Copland et al., 
2003) The experiments conducted in this chapter demonstrate that liposomal delivery of 
inhibitory compounds into intracellular space is a more effective method than 
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conventional regular uptake for all inhibitors used. This is proven by the diminished 
positive population, cells that are actively producing NO. Lower concentrations of 
inhibitors than in some cases in the literature were used. This was to prevent saturation 
of the inhibitory effect; if the system is already saturated then the enhancing effect 
would not have been observable. The target concentration was determined using both 
literature values and IC50 values. We observed that in some cases, a concentration of up 
to 10 mM was used and that the IC50 values were smaller by multiple orders of 
magnitude.(Alderton et al., 2001) Therefore a value that was several times higher than 
IC50 values and several times lower than the methods used in some cases in the work of 
Kojima et al was adopted.(Hirotatsu Kojima, Naoki Nakatsubo, et al., 1998)  
The data gathered also showed that the CHO-K1 cell line is actively expressing the 
mutant copy of eNOS. Although there was not a significant difference in the active 
population between the mutant and wild type controls, this is likely due to the cell 
regulating both its native NOS and the transfected eNOS. This is probably a mechanism 
of self-preservation as cells that are producing NO at high levels may cause 
cytotoxicity. The inhibitors chosen are partially selective towards eNOS when 
compared to nNOS or iNOS. The shift towards the negative population significantly 
larger in PEX mutants compared to wild type. This evidence suggests that cells are 
preferentially silencing their native genes as they are probably unable to suppress the 
mutant gene's promoter as effectively. As the mutant cell line therefore contains a larger 
percentage of its NO produced by eNOS, inhibition would therefore have a stronger 
effect. These findings support the case for the use of liposomal delivery of therapeutic 
agents.  
 
 87 
 
Figure 37 A model regarding the observed effects of inhibitors on both the mutant 
and wild type CHO cell lines.  Blue: NO from wild type NOS machinery. Green: 
NO from inserted PEX plasmid. Uninhibited, both samples display a similar 
overall level of NO. Although both samples decrease in overall NO upon inhibition, 
the mutant cell line decreases substantially more than the wild type sample. The 
overall decrease in both samples suggests that the inhibitors are also targeting the 
wild type NOS machinery. The larger decrease in the mutant cell line would 
suggest that the function of inserted eNOS is severely debilitated in the presence of 
inhibitors. The similarity in the overall NO level between uninhibited samples 
suggests that NO levels are carefully regulated by the cells. The fact that the 
mutant cell line decreases more substantially suggests that the cell is unable to 
regulate the inserted gene as efficiently as it is capable of regulating its own 
internal wild type machinery. The larger decrease in the mutant cell line is also 
indicative of effective transfection with an NOS. 
 
A possible area worth future investigation is the effect of L-arginine on the system. 
Increasing the amount of reaction substrate would allow for higher levels of protein 
activity and may make the observed differences/effects more distinct. As at the moment 
the cells are providing the substrate they can also limit its uptake and thereby inhibit 
some of the protein function. There is also the possibility that this regulatory effect is 
rescuing the cells from exposure to cytotoxic levels of NO.  
 
 
Wildtype Mutant 
Inhibited Uninhibited Inhibited Uninhibited 
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Chapter 4 Chimeric eNOS 
 
4.1 Chemosensitive eNOS 
 
The work detailed in this chapter went towards the creation of novel chimeric 
constructs involving the eNOS gene for both chemical and optical signal detection. 
Both the systems utilize the same NOS isoform, eNOS – obtained from the plasmid 
pEX_EF1_CFP-NOS3 acquired from ATCC. In order to preserve the machine-readable 
output and minimize electrode preparation/fabrication, both systems will use NO as the 
signal output molecule. Therefore, the eNOS gene is the best candidate for both 
systems. 
 
In order to create a chemical signal dependent version of a nitric oxide synthase, 
cells were genetically modified to produce a mutant variant of eNOS (type III NOS). 
This protein is responsible for the catalytic conversion of L-arginine to L-citrulline, 
generating NO as by-product. The eNOS gene was selected for its constitutive 
expression and the fact that many of its properties, in particular the process of 
dimerization are relatively well understood and hence theoretically easier to 
manipulate.(Alderton et al., 2001) 
Design of a chemically induced version of the protein aimed to bypass the 
disadvantageous time lag of promoter activation, therefore a chemical inducer of 
dimerization approach was taken. More information regarding CID's can be found in 
section 1.7  
The genetic manipulation of eNOS has been designed to impede the production of 
NO so that the reaction will only occur in the presence of rapamycin. To this ends, the 
oxygenase and reductase domains of eNOS are separated. As the protein exists as a 
dimer, both domains are required in order for the protein to function and hence for NO 
to be produced. Subsequently each domain is fused to the fragments of the rapamycin 
targeting domains using serine linkers. FKBP12, part of the FK506 rapamycin binding 
protein, will be fused to the 3' of the oxygenase domain whilst FRAP will be attached to 
the 5' of the reductase domain. FKBP12 binds directly to rapamycin, and FRAP binds to 
the FBBP12/rapamycin complex. This results in sequential binding events leading to a 
FKBP12/rapamycin/FRAP complex in the presence of the chemical inducer of 
dimerization (Choi, J. Chen, S.L. Schreiber, & Clardy, 1996). In binding to rapamycin, 
the two domains of eNOS will be brought into close enough proximity to allow the 
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formation of stable dimers and restore the function of the protein, Figure 38. Although 
rapamycin has previously been used as a chemical inducer of dimerization, it has not 
been used to co-localise a split protein in order to retain functionality.  
 
 
Figure 38 Diagram of the rapamycin dependent dimerization of eNOS. The 
concept depends upon the use of two domains known to interact with each other in 
the presence of rapamycin. This brings the two eNOS domains close enough 
together to allow dimer formation and subsequent protein activity. The FKBP12 
fragment responsible for binding to rapamycin will be fused to the 3' end of the 
oxygenase domain of eNOS and FRAP fragment responsible for 
FKBP12/Rapamycin binding will be fused to the 5' end of the reductase domain of 
A 
B 
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eNOS. When rapamycin is present, the FKBP12/Rapamycin/FRAP complex 
formation will cause the two eNOS domains to come close enough together to form 
dimers with other full protein complements from other FKBP12/Rapamycin/Frap 
complexes. A) Three part system of the CID rapamycin system. Fragments of 
FKBP12 and FRAP are used so as to bind sequentially to rapamycin. B) eNOS is 
separated into its oxygenase and reductase domains. These are fused to a fragment 
of FKBP12 and the Frb region of FRAP together with Gly-Ser-Ser-Ser-Ser/ Gly-
Ser-Ser-Ser-Ser linkers. When Rapamycin is introduced to the system the two 
domains of eNOS will come into sufficient proximity to allow protein function. C) 
eNOS domains become sufficiently co-localized to allow dimerization of eNOS and 
subsequent production of nitric oxide. 
 
The creation of fusion proteins is not always successful as it may alter a protein’s 
structure and consequently its function, diminishing, or even abolishing it. Therefore, 
the Rapamycin induction method is a good way to test whether this system can be 
manipulated in such a fashion and would lead to the construction of eNOS sequences 
with different active targets or the refinement of the Rapamycin induction. The latter 
would require the creation of a further step in the pathway to signalling where 
Rapamycin is released in response to the presence of a specific substance, consequently 
promoting NO production.  
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Figure 39 The strategy taken to create a rapamycin CID dependent eNOS.  A) The 
eNOS gene and rapamycin CID system tags Frb and FKBP12 (within plasmid). B) 
Primer locations to clone out the Oxygenase and Reductase domains of eNOS 
separately as well as cloning of the CID tags. C) Amplification of the sequences 
created in B with extension primers complementary to gene fusion target. D) 
Resulting sequences from amplification shown in C; these sequences are now 
prepared for Gibson Assembly. E)  Chimeric sequences created from Gibson 
assembly method for gene fusion. ARG: Arginine, HAEM (Iron Protoporphyrin 
IX Haem), FMN: Flavin Mononucleotide, FAD: Flavin Adenine Dinucleotide, 
NADPH: Nicotinamide Adenine Dinucleotide Phosphate. eNOS co-factor binding 
region data from Alderton et al. (Alderton et al., 2001) 
 
 
The eNOS gene was obtained from the PEX_EF1-CFP_NOS3 plasmid purchased 
from ATCC and the plasmid Sequence is given in Sequence 9. 
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Sequence 9 The PEX_EF1-CFP_NOS3 plasmid sequence. Yellow: EF1 promoter. Orange: 
eNOS gene oxygenase domain. Burgundy: eNOS gene reductase domain. Green: CFP 
marker gene. Red: Kanamycin resistance gene. 
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As shown in Figure 39, the strategy to form a chemo-sensitive eNOS involved 
splitting the eNOS gene into its oxygenase and reductase domains. This was done using 
the following primers: 
 
DNA origin: PEX_EF1-CFP_NOS3  
Oxygenase forward: CAACAAGTTTGTACAAAAAAGCAGGCTCCG 
Oxygenase reverse:  GAC CTT TAA GGA AGT AGC CAA TGC AGT GAA 
  
Reductase forward: AAGGGGGCAGGCATCACCAGGAAG 
Reductase reverse: GATCAACCACTTTGTACAAGAAAGCTGGGT 
 
Following the splitting of eNOS, the two parts of the rapamycin CID system were 
amplified. 
 
DNA origin: Frb-C-TEV plasmid. 
 
Frb forward:  GCCCACCATGGAGATGTGGCACGA 
Frb reverse:  GGTATCAGAGACCATGCTGCTCATGGA 
 
Sequence 10 Frb Sequence from plasmid Frb-C-TEV. Blue: Frb DNA. Green: Linker 
 
DNA origin: FKBP-(GGGGS)x2-N-TEV 
 
FKBP12 forward:  GCCACCATGGGTGTGCAGGTAGAAACAATC 
FKBP12 reverse:   CCACCACCGTCGCCCCCTCCACCAAGGCCG  
 
 
Sequence 11 FKBP12 Sequence from plasmid FKBP-(GGGGS)x2-N-TEV. Blue: Frb 
DNA. Green: Linker 
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The purpose of these genetic amplifications is to create the following chimeras: 
 
Sequence 12: The fused eNOS Oxygenase/Frb fragment. Orange: eNOS Oxygenase 
domain. Burgundy: eNOS reductase domain. Blue: Frb DNA. Green: Gly/Ser 
linker. 
  
Sequence 13 eNOS Reductase/FKBP12 fragment. Orange: eNOS Oxygenase 
domain. Burgundy: eNOS reductase domain. Blue: FKBP12 DNA. Green: Gly/Ser 
linker. 
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After successful cloning of all the target DNA fragments was proven via Gibson 
Assembly; PCR amplification using primers that target the flanking region of the 
assembled proto-chimeric DNA. The objective for this was to add Restriction Enzyme 
binding sites to permit ligation of the resulting chimeric DNA to a target plasmid 
multiple cloning site. The primers used to extend the sequences to allow plasmid 
integration (termed Ligation Primers with the abbreviation “Li”) were: 
 
Forward Li Oxy: GGCCCGAGTCGACCAACAAGTTTGTACAAAAAAGCA 
Reverse Li Oxy: AGCGGCCGCGGTATCAGAGACCAT 
Forward Li Red: GCGGTCGACTTTAGTGAACCGTCAGATCGC 
Reverse Li Red: AAGCGGCCGCACCACTTTGTACAAGAA 
 
In order to produce the full target DNA sequences with the RE sites, the 
Oxygenase/FKBP12 chimera underwent PCR using the Forward Li Oxy and Reverse Li 
Oxy primers. The reductase domain was amplified using the Forward Li Red and 
Reverse Li Red primers. Upon completion of this further sequence extension, the 
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sequences were ready to undergo Restriction Enzyme digestion to render them 
complementary to the plasmid they will be inserted to. 
 The targeted plasmid for sequence ligation was PEX_EF1-CFP_NOS3 and the 
RE sites chosen permitted selection via fluorescence screening. The selected RE sites 
remove the CFP gene from the plasmid, whilst retaining Kanamycin resistance. 
Therefore colonies which survive on Kanamycin plates but do not fluoresce under 435 
nm light will contain the desired mutation. In addition, the restriction sites targeted for 
plasmid integration are of two separate RE: AccI and HpaI. This is to circumvent the 
problem caused by the palindromic nature of RE sticky ends, a problem which leads to 
lack of control regarding the orientation of inserted DNA fragment. Therefore, different 
RE sites should be used and these should create dissimilar overhangs to prevent non-
specific ligation. 
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4.2 Photo-inducible eNOS 
 
In order to construct a light-induced mutant of eNOS, the LOV domain will be fused 
to the eNOS protein so as to produce NO upon light stimulus. By fusing LOV near 
FMN domains of eNOS it is expected that LOV's photo-dependent phosphorylation will 
lead to electron transfer from LOV to an FMN domain of eNOS. This electron would 
then travel along the eNOS natural electron transfer chain and reach the iron-haeme 
core where the catalytic activity takes place. Hence eNOS production of NO will be 
controlled by limiting it to a photoactive state. NO would only be produced when light 
at 385 nm wavelength is shone on the LOV domain of the chimeric eNOS, Figure 40. 
 As previously discussed in section 1.10 LOV domains have been shown to 
interact directly with FMN (flavin mononucleotides) by transferring an electron to 
FMN. This occurs when LOV is in an excited state and is in close enough proximity to 
the FMN molecule. As FMN is a constituent in the natural electron transfer chain of 
eNOS, the strategy in this thesis aims to hijack the ET chain and convert the system 
from dependence on a chemically active electron donor (NADPH) to a photoactivable 
electron donor (LOV). Genetic manipulation involved introducing an LOV domain in 
close proximity to the FMN domains of eNOS in one of three target sites, 3' from the 
FMN domains, 5' from the FMN domains and in between the two FMN domains. 
Multiple LOV introductions are also attempted. However there is a higher chance of 
failure as it will more extensively modify eNOS and therefore affect protein function in 
an unpredictable manner. The relationship between LOV and FMN has lead to the 
development of a family of FbFPs (FMN-based fluorescent proteins) which almost 
exclusively utilize blue light photoreceptors containing LOV domains.(Tielker, Eichhof, 
Jaeger, & Ernst, 2009) FbFPs are particularly useful as their fluorescence is oxygen 
independent allowing for the study of FMN even in anaerobic conditions, including 
anaerobic organisms.(Lobo, C. J. Smith, & E. R. Rocha, 2011) 
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Figure 40 eNOS/LOV fusion strategy. A) The two proteins used to create the 
chimera - eNOS and LOV. eNOS oxygenase and reductase domains are 
represented by different colours. B) Fusion ready segments: eNOS with truncated 
reductase domain (removal of NADPH binding site) and LOV with eNOS 
matching overhang. C) After fusing the segments, a photoactive chimera of eNOS 
is created. D) Light at wavelength of 385nm drives autophosphorylation of the 
LOV domain. LOV can form a covalent bond with FMN in the phosphorylated 
state and therefore donate an electron to the FMN molecule. FMN is also a co-
factor in the electron transfer (ET) eNOS enzyme. Due to its close proximity to the 
FMN domains of eNOS, it is postulated that the Light-activated LOV protein will 
donate electrons to the eNOS enzyme allowing for catalytic activity. E) eNOS 
works by forming dimer structures with a catalytic core. F) Using the novel 
eNOS/LOV chimera, it is proposed that NO production by eNOS will become 
completely NADPH independent and instead acquiring the ability to be Photo-
activated due to the interaction of phosphorylated LOV with the eNOS reductase 
domain. Electron transfer direction illustrated with dotted arrow. 
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Figure 41 LOV insertion strategy for the formation of photoactivable eNOS.  A) 
The eNOS gene with co-factor binding regions marked. B) Primer positions for 
PCR truncation of eNOS at proximal, distal and intermediate points of the FMN 
domains; Cloning out of LOV domains. C) The resulting truncations are then 
extended using primers to create a complementary region between the two fusion 
targets. D) The sequences created in C are prepared to undergo Gibson assembly. 
E) The resulting chimeric genes Photo-NOSα, β and γ (FL1, FL2, FL3). The 
expectation is that at one or more sites LOV excitation from photo stimulus will 
provide electron transfer to FMN thus allowing the protein to function 
independently of the presence of NADPH.  ARG: Arginine, HAEM (Iron 
Protoporphyrin IX Haem), FMN: Flavin Mononucleotide, FAD: Flavin Adenine 
Dinucleotide, LOV: Light, Oxygen and Voltage, NADPH: Nicotinamide Adenine 
Dinucleotide Phosphate. eNOS co-factor binding region data from Alderton et al. 
(Alderton et al., 2001) 
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Figure 42 Multiple views of the hypothetical structure of the chimeric protein. A) 
An approximation of the truncation of eNOS into its oxygenase domain. B) The 
A) 
B) 
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addition of the LOV constructs and the most likely configuration of the resulting 
dimer. Green/Blue: individual chains of the eNOS dimer. Red/Orange: individual 
chains of LOV1/LOV2 as they form the dimer. Figure constructed using 1FOP, 
2Z6D, 1JNU from PDB. 
 
The aim of the proposed system is to hijack the natural eNOS electron transfer 
pathway and thereby drive NO production using electrons donated by excitation of 
LOV rather than NADPH binding. Figure 43 illustrates the proposed flow of electrons 
in the chimeric protein. The final electron donation creates the necessary charge to 
permit the conversion of L-arginine to citrulline. 
 
 
Figure 43 Expected flow of electrons in the eNOS/LOV chimera. LOV is 
phosphorylated by light at 385nm wavelength and in its excited state donates an 
electrode to FMNH2. This is in turn donated to the Iron Haeme core where 
catalytic activity takes place and L-arginine is converted to L-citrulline. 
 
By replacing the NADPH binding site of the eNOS protein with an upstream 
electron transfer chain electron donor the light activating strategy will effectively 
convert a chemically active protein into a photoactive analogue. The blue light receptor 
from Avena sativa contains two light oxygen voltage domains LOV1 and LOV2. These 
photoactive proteins are capable of transferring an electron to FMN domains upon 
excitation at a wavelength of 385 nm. Thus this design will remove the dependence of 
the eNOS protein on the chemical electron donor NADPH and substitute it for a 
photoactive electron donor, LOV1/2. FMN molecules are part of the natural electron 
transfer pathway of eNOS.  In conjunction with other pathway co-factors they transfer 
the electron from the NADPH binding site through the FAD and tetrahydrobiopterin 
domains finally ending at the protoporphyrin IX core (where catalysis occurs). As the 
natural dimerization site of eNOS, the calmodullin binding region remains unaffected 
thus the expectation is that the protein will dimerize normally, with possible 
enhancement via induction of higher intracellular calcium levels.  
FMNH2 
FMNH+ FE3+ 
FE2+ LOV 
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The 3609bp eNOS gene was obtained from the PEX_EF1-CFP_NOS3 plasmid 
purchased from ATCC and originating from Mus musculus, sequence 15 LOV genes 
were obtained from the Nph1 gene contained in the pBABE-mpuro-CTET plasmid 
purchased from Addgene. Its origin is from the Avena sativa plant and its sequence is 
given in Sequence 16. 
 
Sequence 15 The eNOS gene. 
 
 
 
Sequence 16 The NhpI gene. 
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Primers were initially designed to truncate the eNOS gene at three different points in 
the sequence. The strategy was planned so that the protein could be truncated at points 
proximal, intermediate and distal to the FMN binding domain, which allows for two 
separate experiments. The first of these relates to the possibility of eNOS 
photoactivation via the eNOS-LOV chimera. Secondly, the use of the eNOS protein 
truncated at the proximal region of the FMN binding domains which excludes these 
domains from the sequence will serve as a confirmation that LOV can photoactivate the 
eNOS protein only in the proximity of an FMN molecule to which it may donate an 
electron. FMN serves as an electron transfer co-factor in the electron transfer chain of 
native eNOS. 
 The FMN domain binding region of eNOS is given in Sequence 17. This 
Sequence is located 1536 bp downstream from the start site of the eNOS gene and runs 
until 2166 bp. Truncations to the eNOS protein will be centred around this region of 
DNA. The sequences created to serve the purposes discussed are given in sequences 18-
20, where the oxygenase domain is depicted in orange and the reductase domain in 
purple.  
 
Sequence 17 The FMN binding region of eNOS. 
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Sequence 18 The first truncation of eNOS based on FMN domain location. 
Orange: eNOS Oxygenase domain. eNOS Burgundy: Reductase domain. 
 
 
 
Sequence 19 The second truncation of eNOS based on FMN binding domain 
locations. Orange: eNOS Oxygenase domain. Burgundy: eNOS Reductase domain. 
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Sequence 20 The third truncation of eNOS based on FMN binding domain 
locations. Orange: eNOS Oxygenase domain. Burgundy: eNOS Reductase domain. 
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The forward primer for all eNOS sequences is identical as the truncation event 
occurs at a distance from the 5' region of the gene. The reverse primers (all eNOS FMN 
primers) are designed to truncate the gene at different points. 
 
eNOS forward: CAACAAGTTTGTACAAAAAAGCAGGCTCCG 
 
     eNOS FMN 1: ATACAGAATGGTTGCCTTCACACGCTT 
     eNOS FMN 2: GCCAAGAGGATACCAGTGGGTCTGAGC 
     eNOS FMN 3:  CAGCTTTGGCATCTTCTCCCACACAGA 
 
LOV forward: AGGGTTCTGGAAGTGGATCTTTGGCTA 
 
LOV reverse: CGGATCCAAGTTCTTTTGCCGCCTCAT 
 
Sequence 21: LOV cloning. Blue: NhpI gene (containing LOV1-2 domains) 
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Following successful cloning of the truncated eNOS sequence, primers were 
designed to extend the fragments so as to allow Gibson ligation to occur and to insert a 
restriction enzyme binding site: 
 
Forward Li Oxy: GGCCCGAGTCGACCAACAAGTTTGTACAAAAAAGCA 
 
FMN1-LOV FUS: CACTTCCAGAACCCTATACAGAATGGTTGCCTT 
 
FMN2-LOV FUS: TTCCAGAACCCTGCCAAGAGGATACCA 
 
FMN3-LOV FUS: CACTTCCAGAACCCTCAGCTTTGGCATCTT 
  
LOV-FMN1 FUS: GCAACCATTCTGTATAGGGTTCTGGAAGTGGATCTT 
 
LOV-FMN2 FUS: TATCCTCTTGGCAGGGTTCTGGAAGTGGAT 
 
LOV-FMN3 FUS: ATGCCAAAGCTGAGGGTTCTGGAAGTG 
  
LOV Ligation: GTTAACATCCAAGTTCTTTTGCCGCCTCATCAA 
 
Ligation primers contained a RE binding site which will be used to ligate the 
sequence to the plasmid multiple cloning site. FUS primers are used to extend the target 
sequences with a sequence complementary to that of the second fusion sequence. As an 
example, for truncated eNOS-LOV chimera 1, the oxygenase ligation primer was used 
as a forward primer for the truncated eNOS sequence with the FMN1-LOV FUS primer 
as its reverse. The LOV sequence used LOV-FMN1 FUS as its forward primer and the 
LOV ligation primer as its reverse. The same concept was used for all the chimeras 
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formed. The sequences generated by the truncated eNOS-LOV fusion are given in 
sequences 22-24. 
 
Sequence 22 The first eNOS-LOV chimeric gene. Orange: eNOS Oxygenase 
domain. Burgundy: eNOS reductase domain. Blue: LOV domains. 
 
 
 
 
 
 
 
 
 
 
 
Sequence 23 The second eNOS-LOV chimeric gene. Orange: eNOS Oxygenase 
domain. Burgundy: eNOS reductase domain. Blue: LOV domains. 
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Sequence 24 The third eNOS-LOV chimeric gene. Orange: eNOS Oxygenase 
domain. Burgundy: eNOS reductase domain. Blue: LOV domains. 
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4.3 PCR Results 
 
The ladder used to identify fragment size in kB throughout the results presented in 
this section was the NEB 1kb ladder, Figure 44. As can be seen in Figure 45, optimized 
PCR is highly efficient with samples 1-8 showing a product of the expected size. A 
slight shift is observed from left to right. However this is due to uneven gel morphology 
and is not reflective of the sequence size. Previous attempts using different settings, 
such as reduced final extension time or lower annealing temperature resulted in a less 
successful product with fewer or no samples yielding the desired product. Settings for 
the optimized PCR are as follows, with PCR cycles performed between steps two and 
step five for a total of thirty cycles. 
 
1. 98 ºC  -  30s 
2. 98 ºC  -  10s 
3. 72 ºC  -  60s 
4. 62 ºC  -  60s 
5. 58 ºC  -  60s 
6. 72 ºC  -  240s 
 
 
Figure 44 The NEB 1kB ladder. The bands result from the digestion of an 
especially designed plasmid digested with appropriate restriction enzymes. This 
provides a marker with known bp size. Sizes shown are in kB. 
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Figure 45 Result of optimized PCR for synthesis of the eNOS oxygenase domain 
sequence. The expected fragment size is 1540 bp and as can be seen in the image, 
the band is at the 1.5 kB marker. PCR was performed as described above the 
figure using the plasmid PEX_EF1-CFP_NOS3.  
 
Different conditions were used to obtain the eNOS reductase domain. Although 
several conditions were used in the thermal cycles, none were found to be optimal and 
yield of target DNA was lower than in the case of the oxygenase domain. 
 
1. 98 ºC  -  30s 
2. 98 ºC  -  10s 
3. 66 ºC  -  60s 
4. 64 ºC  -  60s 
5. 62 ºC  -  60s 
6. 58 ºC  -  60s 
7. 72 ºC  -  240s 
 
~1.5kB 
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Figure 46 The result of several batches of PCR towards the amplification of the 
reductase domain of eNOS. Several miniprep products of transfected, grown E. 
coli were used. The target product at an approximate size of 2.2KB can be found 
through several lanes of the pictured gel. PCR was performed as described above 
the figure using the plasmid PEX_EF1-CFP_NOS3. 
 
For the 355bp FKBP12 fragment, obtained from the plasmid FKBP-(GGGGS)x2-N-
TEV, the following conditions were found to be optimal. PCR cycles were performed 
between steps two and step six for a total of thirty cycles. 
 
1. 98 ºC  -  30s 
2. 98 ºC  -  10s 
3. 72 ºC  -  30s 
4. 70 ºC  -  30s 
5. 68 ºC  -  30s 
6. 64 ºC  -  60s 
7. 72 ºC  -  420s 
 
~2.2KB 
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Figure 47 The 355bp fragment resulting from the PCR of the FKBP12. PCR was 
performed as described above the figure using the plasmid FKBP-(GGGGS)x2-N-
TEV. The 304bp band can be seen in all samples, but stronger bands (higher 
concentration of DNA) are found in the first and second samples. 
 
The 304bp fragment Frb was successfully amplified using the following PCR 
procedure. PCR cycles were performed between steps two and step six for a total of 
thirty cycles. 
 
1. 98 ºC  -  30s 
2. 98 ºC  -  10s 
3. 64 ºC  -  45s 
4. 60 ºC  -  45s 
5. 72 ºC  -  60s 
6. 72 ºC  -  420s 
~355bp 
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Figure 48 Results from several PCR batches to obtain the 304bp Frb fragment. 
Successfully amplified sequences can be found in: 1: 1-3, 5, 8, 15 2: 8, 9, 14-15. 
PCR was performed as described above the figure using the plasmid Frb-C-TEV. 
 
Once all of the appropriate fragments had been obtained, Touchdown PCR was 
performed to amplify sequences with the appropriate extensions for Gibson Assembly. 
Cycles occur between steps two and ten for a total of thirty cycles. 
Touchdown PCR: 
 
1: 
1. 98 ºC  -  30s 
2. 98 ºC  -  10s 
3. 70 ºC  -  30s 
4. 68 ºC  -  30s 
5. 66 ºC  -  30s 
6. 64 ºC  -  30s 
7. 62 ºC  -  30s 
8. 60 ºC  -  30s 
9. 58 ºC  - 30s 
10.  72 ºC  -  30s 
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11. 72 ºC  -  420s 
 
2: 
1. 98 ºC  -  30s 
2. 98 ºC  -  10s 
3. 72 ºC  -  30s 
4. 70 ºC  -  30s 
5. 68 ºC  -  30s 
6. 66 ºC  -  30s 
7. 64 ºC  -  30s 
8. 62 ºC  -  30s 
9. 60 ºC  -  30s 
10. 72 ºC  -  420s 
 
 
 
Figure 49 Results of Touchdown PCR to obtain extended fragments. A) eNOS 
oxygenase domain. B) eNOS reductase domain. F) Frb fragment K) FKBP12 
fragment. PCR conditions are as those described above and the plasmids used for 
PCR are: A) PEX_EF1-CFP_NOS3 B) PEX_EF1-CFP_NOS3 F) Frb-C-TEV K) 
FKBP-(GGGGS)x2-N-TEV. 
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The fidelity of the produced fragments was verified using Gibson Assembly. Results 
of this experiment can be found in the appropriate section (4.4). Successful fusion 
verified the compatibility of the fragments. Following this step, the fragments were 
extended so as to include binding sites for the appropriate restriction enzymes, so as to 
allow plasmid integration. 
 
4.4 Gibson Assembly. 
 
Gibson assembly was used for two purposes, to verify whether extended sequences 
were correctly formed, and to fuse the sequences so as to create the chimeric gene. 
Gibson Assembly was performed as described in section 2.4.9. 
 
 
 
Figure 50 Gibson assembly results. 1 and 2 are images taken from the same gel 
with a different exposure time to UV. This is necessary due to the low 
concentrations of DNA used in Gibson assembly. AF) eNOS oxygenase domain 
fused to Frb fragment. BK) eNOS reductase domain fused to the FKBP12 
fragment. A clear shift can be seen from the fragment sizes presented in Figure 49. 
The shifts correspond in size to the fusion of the 304bp fragment of Frb to the 
1540bp fragment of the Oxygenase domain of eNOS (AF) and to the fusion of the 
512bp FKBP12 fragment to the 2188bp Reductase domain of eNOS (BK).  
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4.5 Truncated eNOS PCR results 
 
eNOS was truncated at three separate points near FMN domains. Touchdown PCR 
proved ineffective for the formation of truncated eNOS fragments. As a result, 
individual sets of conditions were used to obtain each of the three truncated eNOS 
fragments. 
 
 
 
Figure 51 - Results of three different PCR reactions. 1-5) eNOS truncation 1. 6-10) 
eNOS truncation 2. 11-15) eNOS truncation 3. Three different PCR reactions were 
undertaken as described above. PCR1: 1,6,11. PCR2: 2-3, 7-8, 12-13. PCR3: 4-5, 9-
10, 14-15. As shown, even with attempted optimization, efficiency was not 
increased and varying protocols achieved similar levels of product. 
 
The PCR conditions to achieve the products shown in Figure 51 were different for 
each target sequence. The second truncation of eNOS was the first to be successfully 
amplified using the same PCR conditions as Touchdown PCR 1 described earlier. 
Conditions were as follows: 
 
Touchdown PCR 1: 
 
1. 98ºC  -  30s 
2. 98ºC  -  10s 
3. 68ºC  -  30s 
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4. 66ºC  -  30s 
5. 64ºC  -  30s 
6. 62ºC  -  30s 
7. 60ºC  -  30s 
8. 58ºC  -  30s 
9. 72ºC  -  30s 
10. 72ºC  -  420s 
 
Cycles occur between steps two and nine for a total of thirty cycles. The first and 
third truncations of eNOS were later successfully amplified using a different PCR 
protocol: 
 
1. 98ºC  -  30s 
2. 98ºC  -  10s 
3. 60ºC  -  30s 
4. 58ºC  -  30s 
5. 72ºC  -  30s 
6. 72ºC  -  420s 
 
Cycles occur between steps two and five for a total of thirty cycles. 
 
The LOV fragment was isolated separately. This was achieved by using the 
following temperature cycles. Cycles occur between steps two and five for a total of 
thirty cycles. 
 
 
 
1. 98ºC  -  30s 
2. 98ºC  -  10s 
3. 62ºC  -  30s 
4. 60ºC  -  30s 
5. 72ºC  -  30s 
6. 72ºC  -  420s 
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Following the successful amplification of all target sequences, the targets were 
extended with the extension primers. This was in preparation for fusion of the fragments 
and their subsequent integration into a plasmid. Towards this end, the LOV sequence 
was amplified using the forward primers LOV-FMN1 FUS, LOV-FMN2 FUS, LOV-
FMN3 FUS and the reverse primer LOV LIGATION. 
The eNOS sequence was amplified with the forward primer Forward Li Oxy and the 
reverse primers FMN1-LOV FUS, FMN2-LOV FUS, FMN3-LOV FUS. Doing this 
creates pre-fused fragments that contain a RE site at the 5' region of the eNOS gene and 
a second RE site at the 3' end of the LOV gene. Once the two fragments are then fused, 
there will be two separate and distinct RE sites, one at the 5' region and one at the 3' 
region. This will allow ligation of the sequence into a plasmid digested with the 
corresponding restriction enzymes. 
 
 
 
 
 
 
Figure 52 Gibson Assembly post-PCR. These are results of a Gibson Ligation 
which have been PCR amplified. 2-3: AF.  4-5: BK. 6-7 FMN1/LOV1. 8-9: 
FMN2/LOV2. 10-11: FMN3/LOV3. 12-13: Non-Gibson Ligated fragment A (to 
make a larger stock in case the fusion did not occur.)  
1 2 3 4 5 6 7 8 9 10 11 12 13  
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The results depicted in Figure 52 show that only fusions of AF and FMN1/LOV1 
were successful, yielding fragments of the expected sizes of approximately 1.9kb. 
Fragments that were successfully fused include: A-F, FMN1-LOV1, FMN2-LOV2, 
FMN3-LOV3. Although several attempts were made at achieving the B-K fusion, this 
fragment was, for unknown reasons, unobtainable. 
 
4.6 Ligation 
 
Ligation of the plasmid/insert pre-digested with AccI and HpaI was performed via 
electroporation as described in 2.4.2. The following ligations were performed: 
 
PEX_EF1-CFP/FMN1-LOV1 
PEX_EF1-CFP/FMN2-LOV2  
PEX_EF1-CFP/FMN3-LOV3 
 
A different terminology represents the fact that the NOS3 gene had been cut from 
the plasmid prior to ligation using restriction digest. The following vector/insert DNA 
ratios were used for ligation: 
1:1 
1:3 
1:6 
 
4.7 E.coli Transformation 
 
 Wild type DH5α E.coli was transformed with the resulting ligations: 
 
PEX_EF1-CFP/FMN1-LOV1 
PEX_EF1-CFP/FMN2-LOV2  
PEX_EF1-CFP/FMN3-LOV3 
 
Transformations were performed with all vector/insert DNA ratios discussed in 5.4. 
A control using only vector DNA was also included to ensure that the plasmid was not 
simply re-ligating. Only the following transformations resulted in bacterial growth on 
Kanamycin plates: 
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1:3 ratio vector/insert DNA PEX_EF1-CFP/FMN1-LOV1 
1:6 ratio vector/insert DNA PEX_EF1-CFP/FMN2-LOV2  
1:3 ratio vector/insert DNA PEX_EF1-CFP/FMN3-LOV3 
1:6 ratio vector/insert DNA PEX_EF1-CFP/FMN3-LOV3 
 
All other plates exhibited no growth at 37 °C over a period of 48 hours on 
Kanamycin plates. Following successful transformation of E.coli, the new strains were 
grown for plasmid harvesting via miniprep. The extracted plasmid DNA was then sent 
for sequencing. 
 
 
 
 
 
4.8 Sequencing results 
 
Sequencing of the plasmid DNA proved inconclusive, therefore the following 
experiments were devised: 
 
• Plasmid digestion with AccI and HpaI 
• PCR of plasmid DNA with the appropriate primers for each strain (the primers 
used to create the mutant DNA). (Figures 49 and 51) 
 
4.9 Mammalian Cell Transfection 1 
 
Plasmid DNA harvested from the bacterial mutants was used to transfect the 
mammalian cell line CHO-K1. This cell line has been used by a number of groups to 
express eNOS for mechanistic studies. Transfection was performed using lipofection, as 
described in section 2.2.4 so as to exclude the need for viruses and still obtain a high 
ratio of successful transfection. The following transfections were attempted: 
 
• Unmodified plasmid DNA (PEX_EF1-CFP_NOS3) 
• FMN1-LOV1 mutant version of eNOS (PEX_EF1-CFP) 
• FMN2-LOV2 mutant version of eNOS (PEX_EF1-CFP) 
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• FMN3-LOV3 mutant version of eNOS (PEX_EF1-CFP) 
• Control: no plasmid 
• Control: no transfection protocol administered, instead - media was added to 
replace the volumes used in protocol. 
 
Following the transfection protocol, the cells were allowed to grow for 24 hours 
prior to introduction of the antibiotic for which the plasmid codes a resistance. In this 
case, G418, also known as Geneticin. A killing curve was constructed for all samples as 
it is necessary to confirm cell death in control samples and life in non-control samples. 
The killing curve was measured with cells grown in 5mg/mL of G418, 1 mg/mL G418, 
0.75 mg/mL G418 and 0.5 mg/mL G418. Due to the method of antibiotic selectivity 
conferred by G418, cells were required to grow for one week at 37 °C, 5% CO2 prior to 
confirmation of resistance/non-resistance.  
At the end of the first experiment, only the sample containing unmodified plasmid 
DNA (PEX_EF1-CFP_NOS3) exhibited resistance to G418 at all concentrations. All 
other samples exhibited cell death. 
Following this experiment, a second round of transfection was carried out. In the 
second round of transfection, a replica of the initial transfection was carried out and the 
sample wrapped in sterilized aluminium foil. This was due to the fact that I had been 
unable to rule out a possible cause of cell death: uncontrollable activation of eNOS and 
therefore high levels of NO. As the wild type form of the protein is regulated by the 
availability of both L-arginine and NADPH, the cell would be able to thoroughly 
regulate eNOS activity (such in the case of the surviving sample.) However, if the 
mutant construct had been successful, NO production would only be dependent on L-
arginine presence and light. As in the previous round of transfection this was not 
accounted for, cells may have been exposed to light for an overlong period of time, 
causing the accumulation of NO and possibly triggering cellular apoptosis on a mass 
scale.  
The second round of transfection showed identical results to the first, in both light 
and dark samples, with the added observation that even the PEX_EF1-CFP_NOS3 
sample showed reduced growth in darkenss. This may have occurred due to leftover 
ethanol on the surface of the aluminium foil. Due to the findings described in section 
4.5, this series of experiments was scrapped and only the successful mutant line was 
kept so as to perform further experiments. 
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4.10 Troubleshooting 
 
Plasmid digestion showed negative results, suggesting a non-integration event. PCR 
of the plasmid DNA, however, proved the presence of some individual fragments in the 
DNA. In order to understand what had happened, a review of all procedures to this point 
was performed. A second attempt at transforming E.coli was attempted which yielded 
the same results. An internet search was made to find the plasmid sequence in more 
databases, as this may have been a source of error. The search yielded a slightly 
different plasmid sequence, Sequence 25, from a different source. There were two 
critical differences, location of the CFP gene in the plasmid sequence and the RE site 
map of the plasmid. 
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Sequence 25 The second sequence obtained for the plasmid PEX_EF1-CFP_NOS3. 
Dark blue: EF1 promoter. Light blue: CFP marker gene. Orange: eNOS gene. Red: 
Kanamycin resistance gene. 
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When comparing this plasmid sequence to the one originally obtained from the 
plasmid supplier, it can be seen that the CFP protein locus is now shifted to the anterior 
proximal region of the eNOS gene, rather than the originally though posterior proximal 
region. In addition, due to these changes, RE sites are no longer matching the initially 
proposed strategy. A hypothesis to explain the gain in resistance of the transformed 
bacteria is described in Figure 53.  
 
 
 
Figure 53 Hypothesis regarding the false positives obtained during transfection 
using improper RE sites. A) Depiction of how the ligation process would have 
worked if the plasmid sequence had been as originally thought. B) Depiction of 
how the ligation process probably occurred due to the RE site mismatch. As can be 
seen in B, due to the lack of an HpaI site, only a single cut was made in the 
plasmid. As one end of the insert fragment contained an AccI site, this may have 
bound and then been cut at any of several points due to processing within the 
bacteria. 
 
Control ligation experiments involving only vector DNA did not show signs of self-
ligation of plasmid DNA. In addition, PCR experiments confirmed the presence of the 
LOV DNA within the purified plasmid DNA. To confirm whether this was the case, the 
new plasmid map was analyzed and a restriction digest was planned based on its RE 
AccI site 
 
Insert DNA 
Vector DNA 
A 
B 
HpaI site 
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sites. The enzymes selected were NheI and AccI, which flank the eNOS gene as given 
in the new sequence.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 54 A restriction digest performed on the PEX_EF1-CFP_NOS3 plasmid 
using the following restriction enzymes: A) Nhe1, AccI. B) AccI, HpaI. C) AccI, 
NotI. 
 
No restriction digest yielded the expected ~3.7kB fragment except the AccI-NotI 
digest, Figure 54, the result of which shows more bands than were expected.  The newly 
found sequence does not contain a single NotI site contradicting the possibility that the 
original sequence data was incorrect. Compared to a restriction digest performed in 
earlier work, Figure 55. 
 
 
 
 
A C B 
3kB 
4kB 
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Figure 55 A previously performed restriction digest of PEX_EF1-CFP_NOS3 with 
AccI and NotI. All samples showed the same bands when digested. However, when 
compared to the AccI-NotI digestion described in Figure 54, one can observe the 
dissimilarities. 
 
 The difference in digest results between the two plasmids suggests that the plasmid 
had been mutated by the bacteria prior to harvesting. Although PCR had been 
successful, yielding bands of expected size, it is possible that some regions of the 
plasmid had been mutated. To verify this, frozen master colonies were thawed, plated 
and grown overnight for plasmid DNA extraction together. It would be expected that 
the master colonies would be closer to the original sequence as they are generationally 
closer to the original transformation point.  
Restriction digest of the plasmid extracted from these colonies, however, proved 
identical to those demonstrated in Figure 54. Due to these findings, it was concluded 
that the strategy for plasmid integration required a full re-design. To this end, a new 
plasmid system was obtained. This system, the pTARGETTM Mammalian Expression 
Vector System, was purchased from Promega and works in a completely different 
manner to the previously designed plasmid integration strategy. Rather than relying on 
restriction digests to create complementary regions for plasmid/insert ligation, this 
system provides pre-cut plasmid which contains a poly-T sequence at its 5' ends. The 
system requires insert amplification using a polymerase which does not create blunt end 
sequences, and instead creates 3' poly-A sequences - such as Taq polymerase. 
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Figure 56 The 5.67kB pTarget mammalian expression vector. (Image from 
promega.com) 
 
 The pTARGETTM system contains a gene for Ampicillin resistance and also allows 
for blue/white colony screening by containing a LacZ gene which becomes interrupted 
upon successful insertion of constructs into the plasmid. Therefore, white colonies 
which grow on Ampicillin/IPTG/XGAL plates are likely to contain the construct of 
interest. 
 
4.11 Employing the new strategy 
 
In order to employ this new strategy, all fragments were re-amplified as per the 
original plasmid integration technique described in sections 4.3. 
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Figure 57 Amplification of all individual fragments using primers described in 
sections 4.3 
 
Following this step, fragments underwent Gibson Ligation as described in 2.4.9. The 
resulting fused fragments then underwent PCR using Taq polymerase. It is noteworthy 
that this is the only amplification step which utilizes Taq polymerase due to its low 
amplification fidelity when compared to Phusion polymerase. 
 
 
 
 
 
FMN3 FMN2 FMN1 K F B A LOV3 LOV2 LOV1 
FMN3 
FMN2 FMN1 K F B A 
LOV3 LOV2 LOV1 FMN3 FMN2 FMN1 K F B A LOV3 LOV2  
AF AF BK FL1 FL1 FL2 FL2 FL3 
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Figure 58 Amplification of Gibson Ligation results with Taq Polymerase, yielding 
constructs described in 4.3. 
 
These constructs were then ligated to the pTARGETTM vector, transformed into 
JM109 high efficiency competent cells, and plated on Ampicillin/IPTG/XGAL plates 
for blue/white screening of mutants. White colonies were selected and grown for the 
purpose of plasmid extraction via miniprep protocol. Amplification of the target 
sequences via PCR using the same primers which were used to originally amplify the 
fused constructs was used to verify plasmid integration. After a first round of 
transformation both AFand BK showed white colonies growing on plates, although very 
few colonies were observed. Of these, no white colonies from either mutant grew in a 
100 μg/mL Ampicillin concentration. 
Following this, a second round of ligation/transformation was performed. An 
additional step of gentle centrifugation at 1,000g was employed prior to plating the 
transformants. White colonies were observed for all transformants, however only AF 
mutants grew overnight in LB/Ampicillin. Plasmid extraction and subsequent PCR of 
these yielded the following results: 
 
 
 
 
 
Figure 59 Results of PCR of plasmid extracted from AF, FL1 and FL2 white 
colonies. When compared to Figure 58, only the fourth AF construct and the first 
FL2 construct showed the expected size. 
 
A final verification of the integrity of the construct was made via a restriction digest. 
Only the AF mutant from the rapamycin system was progressed sufficiently to reach 
this verification step. 
AF AF AF AF AF AF FL1 FL1 FL2 FL2 
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Figure 60 Results of Restriction digests of AF, FL2 and FL3 with EcoRI. 1: 
pTARGET empty vector. 2: Inserted fragment 
 
Another attempt was made at creating the BK mutant, but was unsuccessful. Due to 
timeframe issues, the Rapamycin CID system remained incomplete. However, the 
obtained AF mutant was subsequently transfected into the CHO-K1 cell line 
successfully, Figure 61. 
AF AF FL2 FL2 FL3 FL3 
1 
2 
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AF mutantWildtype
FL1 mutant FL2 mutant
PEX mutantFL3 mutant
 
Figure 61 The results of a Geneticin killing curve. As can be observed, both the 
control cell line and the F1 mutant cell line show dead cells. All other samples 
showed living cells after a period of 7 days in Geneticin (G418) 
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4.12 Sensor Selection 
 
Choice of electrochemical sensor to interface with the nitric oxide producing cells 
was based on rapid detection rate and the ability to detect nitric oxide at very low 
concentrations. The sensor used in this work has been demonstrated by McNeil et al for 
the detection of NO production levels in cultured cells.(Chang, Henderson, Cole, F. 
Bedioui, & Mcneil, 2005)  
The sensor type chosen is amperometric, capable of detecting nanomolar 
concentrations of NO and producing a change in current showing a linear relationship 
with the concentration of NO. The electrode works by oxidation of NO resulting in a 
measurable change in the output signal, current in this instance.(Nazaré Pereira-
Rodrigues et al., 2002) A platinum electrode is deposited with a NiTSPc 
(tetrasulphonated nickel phthalocyanine) layer which is then coated with a Nafion 117 
film.   
NiTSPc is deposited via electrodeposition in an alkaline NaOH aqueous solution of 
2 mM NiTSPc at a constant potential of +1.2V versus an Ag/AgCl electrode for a 
period of ten minutes.(Pontie, Gobin, Pauporte, Fethi Bedioui, & Devynck, 2000) 
Subsequently 2 μL Nafion 117 is deposited from a 1.25% concentration in alcohol onto 
the modified electrode surface and left to dry at ambient temperature. The NiTSPc layer 
allows the necessary surface chemistry for the sensor to interact with NO and the Nafion 
117 layer confers further selectivity to the electrode by limiting both the state and size 
range of molecules, thus selecting for gaseous NO.  
 
4.13 Electrode preparation 
 
The electrode was prepared as discussed in the methodology. Shown below are 
cyclic voltammogram curves depicting the electrodeposition of NiTSPc on to the 
platinum surface of the electrode. 
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Figure 62 Cyclic voltammetry results for electrode functionalization.  A) Fresh 
NiTSPc solution, 15 cycles. B) 2nd round of cyclic voltammetry performed on the 
electrode used in A, depicting cycles "16-30". C) Cyclic voltammetry using NiTSPc 
solution which had been left at room temperature overnight. D) Cyclic 
voltammetry curve taken from (Oni et al., 2004) for the same functionalization 
procedure. 
 
As can be seen in Figure 62, subsequent scans between 0-1.2V(+) at 100mV/s show 
peaks representing gradual deposition of NiTSPc on the electrode surface. These curves 
concur with presented peaks in the literature shown in D. As a further experiment, a 
second round of cyclic voltammetry was applied to a functionalized electrode. This 
causes an increase in the amplitude of both peaks as shown in image B of Figure 62. 
The 2mM NiTSPc solution must be kept refrigerated. Failure to do so prevents correct 
electrodeposition. Image C from Figure 62 demonstrates a cyclic voltammogram of the 
electrode in un-refrigerated NiTSPc. This finding shows the importance of modifying 
the electrode surface via cyclic voltammetry as opposed to constant potential, another 
method of achieving the electrodeposition of NiTSPc. By using cyclic voltammetry, 
there is an added assurance to the quality of the prepared electrode. 
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4.14 Electrode Measurements 
 
Various samples were subjected to the modified amperometric measurements. All 
measurements were performed on suspended cells in PBS using the same electrode 
preparation. 
 
 
 
Figure 63 The Cyclic Voltammogram of the electrode used in the experiments 
described. A total of 20 sweeps were made at 0.1V/s, step 0.01V and vertices 0.0-
1.2V. Cycles 2-20 shown. 
 
Samples include:  
 
• Control A - Untransformed Cells.  
• Control B - Cells containing a transfected wild type eNOS gene 
(PEX_EF1_NOS3-CFP).  
• Sample 2 - Truncated eNOS version 2 fused to LOV (FL2). 
• Sample 3 - Truncated eNOS version 3 fused to LOV (FL3). 
• PBS 
Potential 
Cu
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Current vs Potential
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Figure 64 The effect of stimulus in the form of light on the FL3 eNOS mutant. 
Arrows indicate initiation and termination of stimulus. The curve not only shows a 
rapid change in current but also a gradual increase/decrease as more NO becomes 
generated from the mutant protein. 
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Figure 65 The change in current over time for the eNOS mutant FL3 vs the two 
controls: wild type CHO-K1 and CHO-K1 transfected with the PEX plasmid ( wild 
type eNOS) 
 
Evidence presented in Figure 65 strongly favours the conclusion that the FL3 eNOS 
mutant is capable of producing the desired effect, creating a signal transduction pathway 
which transduces an optical signal into a chemical signal.  
Light On 
(all) Light On CTRL 
Light Off 
CTRL 
Light On 
PEX 
Light Off 
PEX Approximation 
of ON area 
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Figure 66 Two samples of FL2 undergoing approximately the same regime of light 
treatment. Although there is a slight decrease in current between runs, this may be 
due to cell number/protein expression levels.  
 
Although an equal number of cells was placed in the 24 well plates, upon 
observation under brightfield microscopy it was noted that cell number was 
approximately the same but with some variation. This may affect the overall level of 
response. 
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Figure 67 A comparison of the effect of light stimuli on a control phosphate 
buffered saline sample and on the FL2 mutant cell line. Although the electrode 
shows some photosensitivity and a similar trend in behaviour, it can be noted that 
the amplitude of change is at least double and that there is no increase over time 
for the PBS sample during the longer stimulus period. A large difference in the 
fast-response amplitude can also be seen between the two samples. 
 
4.15 Discussion 
 
The light inducible version of the eNOS mutants was successfully tested for NO 
production upon optical stimulation and the results confirmed that the designed system 
was functional. Upon the incidence of high intensity visible light an immediate response 
in the form of increased NO production was observed. In addition, the response time of 
the mutant proved activation/deactivation occurred on a sub-second timescale. It 
exhibited switching characteristics in response to on/off type stimuli, Figures 64-67. 
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Both Photo-NOSβ and Photo-NOSγ mutants showed the desired response. The 
implications of the finding that FL2 is photoactive are that either eNOS can function 
using a single FMN domain or that the LOV genes are recruiting their own FMN. As 
FMN is a critical co-factor in the electron transfer pathway of eNOS, knowledge 
regarding its ability to function with just one FMN co-factor is of interest. The  Photo-
NOSα version of the gene was designed to answer this question. Photo-NOSα was 
designed with no eNOS derived FMN binding domains and had the LOV genes attached 
to it at the distal end. If LOV recruits its own FMN then the maximum number of 
possible FMN binding domains is one. At this time, it is not know whether there are two 
or three FMN binding domains in FL3 and whether there are one or two FMN binding 
domains in FL2. 
The fact that the electrode system itself proved to be somewhat photosensitive must 
be considered. This is likely due to the effect of the phthalocyanine moiety in NiTSPc 
and has been reported in the work of Xu et al (H. Xu et al., 1992). Although the group 
demonstrated the effect of light absorption of various phthalocyanines, NiTSPc was not 
investigated. However, they exemplified cases where a phthalocyanine derivative 
allowed for increased absorption of light.  
The evidence towards system overcoming electrode photosensitivity is clear. Using 
the same electrode from the same preparation the difference in activity is very high 
between a sample with control CHO-K1 cells and the mutant cell line. Further evidence 
that the cells are the photoresponsive element stems from the curves depicted in Figure 
67 which show a slower off response than the PBS control.  
The use of inhibitors or L-arginine as well as tetrahydrobiopterin would provide 
relevant evidence of the experiments described in this body of work. Should the signal 
decrease upon use of inhibitor and increase when surplus substrate is present then the 
system can both be characterized further and more effectively.(Klatt et al., 1994) 
 A more standardized measurement regime would also be beneficial. The following 
two methods would most likely yield interesting results. Firstly, an experiment 
demonstrating the system's responsivity by applying a stimulus regimen with periods of 
100 seconds on and 100 seconds off. It may be that the extra NO being generated is 
damaging cells and after several long cycles there will no longer be living cells 
producing NO. Secondly, the fast-response mechanism would be investigated using 
light pulses of varying duration. By testing the fast-response it may yield information 
regarding NO accumulation in cells. As the compound has a half life of a few seconds, 
it may be that repeated bursts of stimuli will slowly raise the background levels of NO 
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but keep the overall level lower than in the experimental methodology described 
previously.  
Three attempts at sequencing the mutants failed. This was most likely due to a step 
in the protocol for sample preparation where the DNA sample is washed with a solution 
containing ethanol. However, plasmid digestion with EcoRI showed that there was a 
fragment of the expected size within the plasmid used for transfection. In addition, PCR 
of the extracted plasmid with the appropriate primers demonstrated successful 
amplification of the target area of DNA. Further evidence towards the success of the 
target DNA insertion includes the differences in sample photosensitivity between cell 
lines which were proven to be transfected with the modified pTARGET plasmids and 
wild type cells. Repeating these experiments with the wild type eNOS gene under a 
pTARGET vector would grant further robustness to the presented data. As all data 
generated via experiments pointed towards a working system, confirming the presence 
of both the plasmid and the fragments as well as the operation of the inserted system. A 
strong body of evidence supports the presence of the target gene. Sequencing using a 
different protocol for sample preparation should yield results. 
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Chapter 5 Conclusions 
 
The experimental work performed in this thesis lead to novel findings regarding 
eNOS and its inhibition. Flow cytometry analysis of CHO-K1 samples found that the 
use of a liposomal delivery method for inhibitor/cell interaction was highly effective. 
The difference was found to be significant (p<0.01) and the protocol enhanced inhibitor 
activity. This difference is increased in the mutant cell line transfected with the 
PEX_EF1-CFP_NOS3 plasmid containing wild type eNOS protein. The statistical 
significance of this data was also found to be p<0.01. These findings served a double 
purpose: to investigate the properties of liposomal delivery of inhibitors and to confirm 
the suitability of the CHO-K1 cell line for expression of mutant constructs of an eNOS 
nature. Due to the difference found between the mutant and wild type NO production 
trends, a model regarding cellular regulation of NO in compensation for the inserted 
protein was created. The model states that the cell, in order to cope with the inserted 
mutation and limit overall NO will limit its own NOS machinery on a transcriptional 
level. This would explain the reason behind the bellow wild type cell baseline levels of 
NO observed in the mutant cell line when exposed to inhibitors. Repeating these 
experiments with the inserted gene under different promoters would be an ideal method 
to validate this hypothesis. 
These findings also highlighted the possible use of CHO-K1 cells to create the cell-
based biosensor for Cyberplasm. Two strategies were developed to create inducible 
eNOS chimeric variants. The designed constructs were to allow for a chemically 
induced NO response and an optically induced NO response respectively. 
A chemically induced form of eNOS based on the rapamycin CID system was 
designed and all individual parts have been created via PCR. However, only half of the 
system was successfully introduced into mammalian cells. As the system absolutely 
requires both halves to function; the rapamycin system remains incomplete and 
untested. In order to reach testing stage of a chemically induced eNOS, the remaining 
fragment must be successfully integrated into plasmids, bacteria and then mammalian 
cells. 
The light induced cell-based biosensor was found to be functional. When compared 
with suitable controls, levels of NO increased dramatically upon light incidence in both 
mutant cell lines Photo-NOSβ and Photo-NOSγ. The response time of the cell-based 
biosensor appears to be within seconds or subseconds. Both a fast response and a 
gradual, slow response were observed. The system also demonstrated a fast switching 
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ability, which is important for its end application. Further experimentation and 
characterization of the biosensor is necessary prior to integration into more complex 
systems such as Cyberplasm. However, the results presented suggest that a signal 
transduction pathway was created within the mutant cell line. This pathway was capable 
of translating an optical signal into a chemical signal which when combined with the 
appropriate electrode system, created a change in current in response to light incidence. 
These properties fit the requirements of Cyberplasm and it is proposed that with the 
right program development an array of cells combined with electrodes may serve as a 
navigation system for the bio-robotic hybrid.  
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Chapter 6 Future Work 
 
Further characterization and standardization of the light-induced NO pathway is 
required. Should the sensor prove quantitative as well as qualitative through further 
investigation, which is likely, the usefulness of this designed system is increased 
manifold. In order to further develop the sensor, several methods are suggested. Firstly, 
a narrowing of the wavelength of light may elucidate the exact wavelengths of 
activation. This may even bypass electrode photosensitivity as the electrode may be 
stimulated by a different wavelength than the mutant construct. In addition, this opens 
the system to the use of bioluminescence. If a gene is tagged with a fluorophore capable 
of emitting light at the wavelength that causes FL2 or FL3 activation, it may be possible 
to appropriate the designed system for gene/protein detection purposes and thereby link 
gene/protein presence to NO. This may have profound implications in the study of gene 
regulation and protein activity.  
In order to further develop the system, studies on adherent cells may be useful. By 
immobilizing cells in Cellagen© it will become possible to place cells at a fixed 
distance from the electrode, standardizing measurements further and preventing cellular 
exposure to high potentials. 
 
Pt Electrode
NiTSPc deposited 
layer
Cellagen© “cage”
Cells
Naffion® 117 layer
 
Figure 68 Schematic representation of the complete proposed sensor system.  
 
The electrochemical sensor has the potential to be miniaturised and fabricated in 
electrode arrays allowing for use in a variety of applications. In order to increase the 
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signal/noise ratio, superoxide production can be inhibited in the cells by incubating cells 
with superoxide dismutase.(Chang, Henderson, Cole, F. Bedioui, & Mcneil, 2005) The 
presence of superoxide will also be further inhibited by the presence of H4 biopterin, a 
co-factor for the enzyme producing NO in the cells in question.  
The work of Oni et al demonstrated the idea of using a Cellagen layer is proposed as 
a method of suspending the cells so that they are not in direct contact with the 
sensor.(Oni et al., 2004) By positioning the sensor a fixed distance away from the cells, 
the effect of the constant potential on the cells can be diminished. The importance of 
using Cellagen membranes is discussed in (Castillo et al., 2005). For many sensors this 
increased distance could prove crippling for detection, but the high diffusion rate of NO 
still allows for a fast response from the sensor and very little noise from background 
NO.  
Another consideration in assessing the feasibility of measuring NO from the system 
is the optimum distance between electrode and cells. Due to its low half-life, availability 
of NO plateaus relatively quickly. As the electrode setup only requires a concentration 
of a few nM to recognize the signal, the system will work through a range of distances, 
but this would affect the timescale of detection. Placing cells in close proximity to the 
electrode will create conditions where cells are exposed to high potentials. In such 
environments, cells tend to agglomerate and clump as well as exhibiting unusual 
morphology (Oni et al., 2004).  
One possible route for the appropriation of this sensor is to link NO production to 
GPCR activation. GPCRs (G-Protein Coupled Receptors) are a class of receptors 
responsible for the detection of a variety of signals and cause the release of a cascade of 
protein activation on several levels; from expression to phosphorylation, activating 
different pathways.(Hur & K.-tai Kim, 2002),(Selbie & Hill, 1998) If it will be possible 
to attach a fluorophore with an emission spectrum matching the absorption of the 
constructed mutants to a GPCR that will activate upon analyte detection, NO production 
would then be directly linked to GPCR activation in cells. This would allow the creation 
of a real-time machine readable signal confirming GPCR activation and thus the 
presence of the triggering chemical/odorant. The challenge with this approach lies in 
finding a place in the cascade of events related to GPCR signalling which influences 
NO production without interfering with other signalling events and without causing 
positive or negative feedback loops.  
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